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Abstract 
Organ dose is the absorbed radiation energy from ionizing radiation to an organ, divided by 
the organ mass. Organ doses of a patient cannot be measured directly in the patient, but their 
determination requires dose measurements in anthropomorphic patient models i.e. 
phantoms or Monte Carlo simulations. Monte Carlo simulations can be performed for 
example by using computational phantoms or patient’s computed tomography (CT) images. 
Organ doses can be estimated based on measurable dose quantities, such as air kerma, 
kerma-area product and volume-weighted CT dose index, by using suitable conversion 
coefficients. Conversion coefficient is the organ dose divided by the measured or calculated 
examination-specific dose quantity. 
According to the current knowledge, the probability of radiation induced stochastic effects, 
which include cancer risk and risk of hereditary effects, increases linearly as a function of 
the radiation dose. The organ dose is a better quantity for estimating the patient specific risk 
than the effective dose, which is meant to be used only for populations, and it does not 
consider patient age or gender. Moreover, the tissue weighting factors that are used in the 
effective dose calculation are based on whole body irradiations, but in X-ray examinations 
only a part of the patient is exposed to radiation. 
The phantoms used in medical dosimetry are either computational or physical, and 
computational phantoms are further divided into mathematical and voxel phantoms. 
Phantoms from simplified to as realistic as possible have been developed to simulate 
different targets, but the organ doses determined based on them can differ largely from the 
real organ doses of the patient. There are also standard and reference phantoms in use, which 
offer a dose estimate to a so called average patient. Due to the considerable variation within 
patient anatomies, the real dose might differ from the dose to a standard or reference 
phantom. 
The aim of this thesis was to determine organ doses based on dose measurements and Monte 
Carlo simulations in four X-ray imaging modalities, including general radiography, CT, 
mammography and dental radiography. The effect of the patient and phantom thickness and 
radiation quality on the organ doses in a projection X-ray examination of the thorax was 
studied via Monte Carlo simulations by using both mathematical phantoms and patient CT 
images. The effect of the breast thickness on the mean glandular doses (MGDs) was 
determined based on measurements with phantoms of different thicknesses and collected 
diagnostic and screening data from patient examinations, and the radiation qualities used in 
patient and phantom exposures were studied. For fetal dose estimation, fetal dose 
conversion coefficients were determined based on phantom measurements in CT and dental 
radiography examinations. Additionally, the effect of lead shields on fetal and breast doses 
was determined in dental examinations.  
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The difference between Monte Carlo simulated organ doses in patients and mathematical 
phantoms was large, for the examined organs up to 55% in projection imaging. In 
mammographic examinations, the difference between MGDs calculated based on collected 
patient data and phantom measurements was up to 30%. In mammography, patient dose 
data cannot be replaced by phantom measurements. The properties and limitations of the 
phantoms must be known when they are used. 
The estimation of the fetal dose based on conversion coefficients requires understanding 
about the cases where conversion coefficients are applicable. When used correctly, they 
provide a method for simple dose estimation, where the application specific dose quantity 
can be taken into account. The conversion coefficients determined in this thesis can be used 
to estimate the fetal dose in CT examination based on the volume-weighted CT dose index 
(CTDIvol), and in dental examinations based on the dose-area product (DAP).  
In projection imaging, the lung and breast doses decreased as the patient’s anterior-posterior 
thickness increased, but in mammography, the MGDs increased as the compressed breast 
thickness increased. In CT examinations, the fetal dose remained almost constant in 
examination where the fetus was totally within the primary radiation beam. When the fetus 
was outside of the primary beam, the fetal dose increased exponentially with the decreasing 
distance of the fetus from the scan range. As a function of the half value layer (HVL), the 
conversion coefficients in the studied projection imaging examination were more 
convergent than as a function of the tube voltage. The HVL alone describes better the 
radiation quality than the tube voltage alone, which requires also the definition of the total 
filtration. In mammography, it is possible to irradiate a phantom and a patient with the same 
equivalent thickness with different radiation qualities when automatic exposure control is 
used. 
Despite the relatively large shielding effect achieved with lead shielding in dental imaging, 
the fetal dose without lead shielding and the related exposure-induced increase in the risk 
of childhood cancer death are minimal (less than 10 μGy and 10-5 %), so there is no need 
for abdominal shielding. The exposure-induced increase in the risk of breast cancer death is 
of the same order of magnitude as the increase in the risk of childhood cancer death, so also 
breast shielding was considered irrelevant. Most important is that a clinically justified dental 
radiographic examination must never be avoided or postponed due to a pregnancy.  
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Tiivistelmä 
Elinannoksella tarkoitetaan elimeen ionisoivasta säteilystä absorboitunutta säteilyenergiaa 
jaettuna elimen massalla. Potilaan elinannoksia ei voi mitata suoraan potilaassa, vaan niiden 
määrittämiseen on käytettävä annosmittauksia ihmistä jäljittelevissä potilasvastineissa eli 
fantomeissa tai Monte Carlo simulaatioita. Monte Carlo simulaatioita voidaan tehdä 
käyttäen esimerkiksi laskennallisia fantomeita tai potilaan tietokonetomografiakuvia (TT-
kuvia). Elinannoksia voidaan arvioida mitattavissa olevien annossuureiden, kuten 
ilmakerman, kerman ja pinta-alan tulon ja TT:n tilavuusannosindeksin, perusteella käyttäen 
sopivia konversiokertoimia. Konversiokertoimella tarkoitetaan elinannoksen ja mitatun tai 
lasketun tutkimuskohtaisen annossuureen suhdetta. 
Nykykäsityksen mukaan säteilyn aiheuttamien satunnaisten vaikutusten todennäköisyys, 
joihin kuuluvat syöpäriski ja perinnöllisten vaikutusten riski, kasvaa lineaarisesti 
säteilyannoksen kasvaessa. Elinannos on parempi suure potilaskohtaisen riskin arviointiin 
kuin efektiivinen annos, joka on tarkoitettu käytettäväksi ainoastaan väestötasolla, eikä se 
huomioi potilaan ikää tai sukupuolta. Lisäksi efektiivisen annoksen laskennassa käytettävät 
kudosten painotuskertoimet perustuvat kokokehosäteilytyksiin, mutta röntgentutkimuksissa 
vain osa potilaan kehosta altistuu säteilylle. 
Lääketieteellisessä dosimetriassa käytetyt fantomit ovat joko laskennallisia tai fysikaalisia, 
ja laskennalliset fantomit jaetaan edelleen matemaattisiin ja vokselifantomeihin. Fantomeita 
yksinkertaistetuista mahdollisimman realistisiin on kehitetty simuloimaan erilaisia kohteita, 
mutta niiden avulla määritetyt elinannokset voivat poiketa suurestikin potilaan todellisista 
elinannoksista. Käytössä on myös standardi- ja referenssifantomeita, joilla saadaan 
annosarvio niin sanotulle keskimääräiselle potilaalle. Koska potilaiden ominaisuudet 
vaihtelevat huomattavasti, saattaa todellinen annos poiketa standardi- tai referenssifantomin 
annoksesta. 
Tämän työn tarkoituksena oli määrittää elinannoksia annosmittausten ja Monte Carlo 
simulaatioiden perusteella neljässä röntgenkuvausmodeliteetissa, mukaan lukien 
natiiviröntgentutkimukset, TT-tutkimukset, mammografiatutkimukset ja 
hammasröntgentutkimukset. Potilaan ja fantomin paksuuden ja säteilylaadun vaikutusta 
elinannoksiin rintakehän projektiotutkimuksessa selvitettiin Monte Carlo simulointien 
avulla käyttäen sekä matemaattisia fantomeita että potilaiden TT-kuvia. Rinnan paksuuden 
vaikutus keskimääräisiin rauhaskudosannoksiin mammografiassa määritettiin käyttäen 
mittauksissa eri paksuisia rintafantomeita sekä kerättyä diagnostista ja 
seulontamammografiadataa potilastutkimuksista, sekä tarkasteltiin potilas-ja 
fantomisäteilytyksissä käytettyjä säteilylaatuja. Sikiön annosarviointia varten määritettiin 
fantomimittausten avulla sikiön annoksen konversiokertoimia TT- ja 
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hammasröntgentutkimuksille. Lisäksi määritettiin lyijysuojien vaikutus sikiön ja rintojen 
annoksiin hammasröntgentutkimuksissa. 
Eron potilaiden ja matemaattisen fantomin Monte Carlo simuloitujen elinannosten välillä 
todettiin olevan suuri, tarkasteltujen elinten osalta enimmillään 55% 
projektiotutkimuksissa. Mammografiatutkimuksissa ero kerätyn potilasdatan ja fantomien 
annosmittausten perusteella laskettujen keskimääräisten rauhaskudosannosten välillä oli 
enimmillään 30%. Mammografiassa fantomimittaukset eivät voi korvata 
potilasannosmäärityksiä. Fantomeiden ominaisuudet ja rajoitukset on tiedettävä niitä 
käytettäessä. 
Sikiön annoksen arviointi konversiokertoimien avulla vaatii ymmärrystä siitä, mihin 
tilanteisiin konversiokertoimet soveltuvat. Oikein käytettynä ne tarjoavat menetelmän 
yksinkertaiseen annosarviointiin, jossa tutkimuskohtainen mitattavissa oleva annossuure 
voidaan ottaa huomioon. Tässä työssä määritettyjen konversiokerrointen avulla voidaan 
arvioida sikiön annosta TT-tutkimuksissa TT:n tilavuusannosindeksin avulla ja 
hammasröntgentutkimuksissa annoksen ja pinta-alan tulon avulla. 
Projektiokuvauksessa potilaan anterior-posterior paksuuden kasvaessa keuhkojen ja 
rintojen annokset pienenivät, mutta mammografiassa keskimääräinen rauhaskudosannos 
kasvoi puristetun rinnan paksuuden kasvaessa. TT-tutkimuksissa sikiön annos pysyi eri 
raskausvaiheissa automaattisen putkivirran modulaation takia lähes vakiona sellaisissa 
tutkimuksissa, joissa sikiö oli kokonaan primäärisäteilykeilassa. Kun sikiö oli 
primäärisäteilykeilan ulkopuolella, sikiön annos kasvoi eksponentiaalisesti kun sikiön 
etäisyys kuvausalueen reunaan pieneni. Puoliintumispaksuuden (HVL) funktiona 
konversiokertoimet tarkastellussa projektiotutkimuksessa olivat yhtenäisemmät kuin 
putkijännitteen funktiona. Pelkkä HVL kuvaa siis paremmin säteilylaatua kuin pelkkä 
putkijännite, joka vaatii myös kokonaissuodatuksen määrittelyn. Mammografiassa on 
mahdollista automaattista säteilytysohjausta käytettäessä säteilyttää 
ekvivalenttipaksuudeltaan toisiaan vastaavat fantomi ja potilas eri säteilylaadulla. 
Huolimatta lyijysuojauksella saavutetusta suhteellisesti suuresta annossäästöstä, sikiön 
annos ilman lyijysuojaa ja siihen liittyvä säteilystä aiheutuva lisäriski lapsuusiän 
syöpäkuolemalle ovat minimaalisia (alle 10 μGy ja 10-5 %), joten tarvetta vatsan alueen 
suojaukselle hammasröntgentutkimuksissa ei ole. Säteilystä aiheutuva lisäriski 
rintasyöpäkuolemalle on samaa suuruusluokkaa kuin lisäriski lapsuusiän syöpäkuolemalle, 
joten myöskään rintojen suojaus ei ole tarpeen. Tärkeintä on, että kliinisesti oikeutettua 
hammasröntgentutkimusta ei pidä koskaan välttää tai lykätä myöhemmäksi raskauden takia. 
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AIMS OF THE STUDY 
 
The specific aims of the research described in this thesis are 
1) Compare doses to simplified patient models with doses to patients (I, III), 
 
2) Provide measurement-based conversion coefficients for the estimation of the fetal 
dose in computed tomography and in dental X-ray examinations (II, IV), 
 
3) Determine the effect of patient size (I, II, III) and radiation quality (I, III) on the 
dose conversion or absolute doses, 
 
4) Determine the effect of lead shields in dental X-ray examinations during 
pregnancy (IV). 
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Study I 
 
Kelaranta A, Toroi P, Vock P. Organ dose conversion factors in thorax X-ray examinations: the 
effect of patient thickness and radiation quality. Submitted in revised form to Physica Medica: 
European Journal of Medical Physics 3.9.2016. 
 
Monte Carlo simulations of a thorax posterior-anterior examination were used to determine the 
effect of patient thickness and radiation quality on the lung and breast organ dose conversion factors. 
The effect of patient thickness was studied by using computed tomography (CT) examination data 
for adult male and female patients of different anterior-posterior thicknesses and thickness-adjusted 
mathematical phantoms, and the effect of different radiation qualities based on a standard-sized 
mathematical phantom. 
 
Study II 
 
Kelaranta A, Kaasalainen T, Seuri R, Toroi P, Kortesniemi M, 2015. Fetal radiation dose in 
computed tomography. Radiation Protection Dosimetry (2015) 165, 1-4, s. 226-230. 
 
An adult female anthropomorphic phantom was scanned with a 64-slice CT scanner, and doses were 
measured with ten metal-oxide-semiconductor field-effect transistor (MOSFET) dosimeters placed 
inside the phantom. The fetal dose was determined in different stages of pregnancy (12, 20, 28 and 
38 weeks) in trauma, abdomino-pelvic and pulmonary angiography CT protocols. Fetal dose 
conversion factors were calculated relative to the volume-weighted computed tomography dose 
index (CTDIvol) for each pregnancy stage and CT protocol. The pulmonary angiography CT scan 
was used to study the effect of scan range proximity on the fetal dose. 
 
Study III 
 
Kelaranta A, Toroi P, Timonen M, Komssi S, Kortesniemi M, 2014. Conformance of mean 
glandular dose from phantom and patient data in mammography. Radiation Protection Dosimetry  
(2014). 164, 3, s. 342-353. 
 
The conformance of the mean glandular dose (MGD) obtained with polymethyl methacrylate 
(PMMA) phantom measurements was evaluated in comparison with the MGD determined for 
patients in diagnostic and screening mammography based on the collected patient exposure 
parameters. The average compressed breast thickness from the collected patient data of Finnish 
women was determined and its congruence with the reference breast thickness range was evaluated 
corresponding to the diagnostic reference level of MGD. 
 
Study IV 
 
Kelaranta A, Ekholm M, Toroi P, Kortesniemi M. Radiation exposure to fetus and breasts from 
dental X-ray examinations: effect of lead shields. Dentomaxillofacial Radiology (2016) 45, 
20150095. 
 
Dose measurement based upper estimates of radiation exposure to the fetus and the breasts were 
determined in different dental X-ray examinations, including intraoral, panoramic, cephalometric 
and cone beam computed tomography (CBCT) examinations, both with and without lead shielding 
by using an adult female anthropomorphic phantom. Dose conversion coefficients were calculated 
as doses per the dose-area product (DAP) values of the dental examinations for a directional 
estimation of the dose to the fetus and breasts. 
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1. Introduction 
 
Diagnostic radiology is one of the most common fields to use the benefits of X-rays. 
Minimizing the disadvantages of ionizing radiation is the driving force of radiation 
protection. A basic principle in radiation protection is the ALARA principle, which is an 
acronym for as low as reasonably achievable (ICRP 2007). It summarizes the approach to 
ionizing radiation according to the current knowledge; in the region of low doses, the 
probability of radiation detriment increases as a function of increasing radiation dose (ICRP 
2007). 
According to the most recent report, the number of X-ray examinations performed in 
Finland in 2011 was approximately 3.7 million, excluding dental surgery X-ray 
examinations (Helasvuo 2013). Of this number, approximately 9 % were computed 
tomography (CT) examinations and 89 % were conventional and contrast media X-ray 
examinations. The most common CT examinations were head, whole body, abdomen and 
thorax scans and the most common conventional X-ray examinations were thorax and 
mammography. Additionally, the number of dental radiographs taken annually in Finland 
is approximately 2.7 million. In 2014, the number of intraoral, panoramic, cephalometric 
and cone beam computed tomography (CBCT) examinations in Finland was 2.4 million, 
300 000, 35 000 and 7 500, respectively (T Helasvuo, June 11, 2015, personal 
communication). Even though the number of X-ray examinations has decreased from 4.6 
million in 1984 to 3.7 million in 2011, the number of CT examinations has increased 
together with the collective radiation dose accumulated from CT examinations (Helasvuo 
2013; Brenner 2010). 
 
In X-ray imaging, the patient receives a certain amount of radiation energy through 
absorption processes. The radiation that passes through the patient is attenuated according 
to the properties of the organs and tissues. The radiation sensitivities of different organs and 
tissues vary. The radiation energy absorbed in a tissue or an organ divided by the tissue or 
organ mass is the organ dose. Organ dose determination is most fundamental part of 
estimating the radiation risk of an individual. Organ doses cannot be measured directly and 
the selected method for organ dose determination has a marked impact on the uncertainty 
related to the organ doses. 
The radiation detriment effects can be either deterministic or stochastic. Deterministic 
effects of radiation are related to high dose levels and cause injury and loss in populations 
of cells. Deterministic effects have a threshold dose below which no clinically visible effects 
are observed. The severity of the effect increases as a function of dose. Stochastic effects 
consist of cancer risk and hereditary effects, and the probability of an effect, but not its 
severity, increases as a function of dose without a threshold (ICRP 2007). The radiation 
effect classification, dose limitation concepts, and the definition of detriment and threshold 
have undergone several changes in the past decades (Hamada & Fujimichi 2014). 
The International Commission on Radiological Protection (ICRP) has defined and 
introduced the concept of effective dose for risk management purposes, and the tissue 
weighting factors for the calculation of the effective dose. The tissue weighting factors are 
based on epidemiological cancer incidence studies and risk estimation of hereditary diseases 
(ICRP 2007). Initially, the tissue weighting factors are based on atomic bomb survivor data 
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with whole-body exposures, but in X-ray imaging organs and tissues receive partial or 
heterogeneous exposure. The tissue weighting factors are intended to apply to a population 
of both genders and all ages, not for an individual. The tissue weighting factors change every 
decade or so due to increased knowledge about radiation effects, but also because different 
ICRP committees might chose to put more emphasis on for example cancer incidence rather 
than cancer mortality. The latter is the case for breast, the tissue weighting factor of which 
has increased from 0.05 to 0.12 in ICRP publications 60 and 103, respectively (ICRP 1991; 
ICRP 2007). 
However, there has been criticism and discussion of the concept of effective dose (Brenner 
2008; Dietze et al. 2009; Brenner 2012). It has often been misused and the confusion 
between equivalent dose and effective dose is widespread in the field of radiology. Proposal 
of a replacing quantity has been made (Brenner 2008; Brenner 2012), but the concept of the 
effective dose still remains in radiation protection. It has been stated that the individual 
organ dose is a better measure for estimating the patient risk, because the effective dose is 
intended for estimating the radiation exposure of entire populations and not for individuals 
(Brenner & Hall 2007; Martin 2007; Zhang et al. 2012; Hall & Brenner 2008; Brenner et al. 
2003). In some of the recent publications, the organ doses are used in the estimation of the 
patient risk instead of the effective dose (Blaszak & Juszkat 2014; Saltybaeva et al. 2016), 
but as the effective dose is a traditional dose quantity, it is still being commonly used in the 
literature. Moreover, the United Nations Scientific Committee on the Effects of Atomic 
Radiation (UNSCEAR) has strongly emphasized, that the effective dose is not directly 
applicable to interpretation of data on health effects because it is developed for radiation 
protection purposes (UNSCEAR 2008a; UNSCEAR 2008b). However, it can be used to 
allow comparison of different types of examinations, equipment and technique factors from 
a risk point of view, but there is no need to quantify any risk coefficients as the detriment 
or risk per effective dose (IAEA 2007). 
This thesis concentrates on organ dose determination based on dose measurements or Monte 
Carlo simulations in four diagnostic X-ray imaging modalities: general radiography, CT, 
mammography and dental radiography. The differences between doses to patients and 
simplified patient models are compared in mammography and general radiography. The 
effect of patient size on the dose conversion coefficients or absolute doses is determined in 
general radiography, CT and mammography and the effect of radiation quality on the dose 
conversion coefficients or absolute doses is determined in general radiography and 
mammography. Results on measurement based conversion coefficients are given for fetal 
dose estimation in CT and dental X-ray examinations and the effect of lead shielding in 
dental X-ray examinations is determined. 
2. Background 
2.1. Dose quantities 
 
The dose quantities can be divided into basic dosimetric quantities, application specific 
dosimetric quantities and quantities related to stochastic and deterministic radiation effects 
(IAEA 2007; ICRU 2005). The relevant basic dosimetric quantities in this thesis are the 
kerma K and the absorbed dose D. The relevant application specific dosimetric quantities 
are the incident air kerma Ka,i, the entrance air kerma Ka,e, the X-ray tube output Y(d), the 
air kerma–area product, KAP or PKA, the air-kerma-length product PKL and CT air kerma 
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indices. The relevant quantities related to stochastic and deterministic radiation effects are 
the organ dose DT, the equivalent dose HT, the effective dose E and the mean glandular dose 
(MGD or DG). This thesis introduces the dosimetric quantities and uncertainty estimation 
according to Technical Report Series (TRS) publication No. 457 and report No. 74 of the 
International Commission on Radiation Units and Measurements (ICRU) (IAEA 2007; 
ICRU 2005). In this thesis, the term uncertainty is preferred over the term accuracy, because 
the term accuracy assumes that the true value of some quantity can be exactly measured, 
which is not possible in reality. The relevant dose quantities are shown in Figure 1. 
The kerma (kinetic energy released per unit mass) K is the sum of the initial kinetic energies 
of all the charged particles liberated by uncharged particles, dEtr, in a mass dm of material, 
and it is defined as 
 
? ? ??????     (1) 
 
The absorbed dose D is the mean energy d? ̅ imparted to matter of mass dm, and it is defined 
as 
 
? ? ?????    (2) 
 
In the case of charged particle equilibrium, the numerical values for K and D are equal. 
 
The air kerma Ka is measured free in air at the focus-to-chamber distance (FCD), and can 
be corrected to represent the incident air kerma Ka,i measured on the central beam axis at 
the position of the patient or phantom surface at focus-to-skin distance (FSD) by using the 
inverse-square law. Only the radiation incident on the patient or phantom is included in Ka,i.  
 
???? ? ?? ????????
?
   (3) 
 
The assumptions for Equation (3) include air attenuation of photons at the zero level, which 
is strongly dependent on the energy. Also, scattered radiation in the primary beam is 
excluded. 
 
The entrance surface air kerma, Ka,e, is the kerma to air measured on the central beam axis 
at the position of the patient or phantom surface. The radiation incident on the patient or 
phantom and also the backscattered radiation are included.  The entrance surface air kerma 
Ka,e is related to the incident air kerma Ka,i by the backscatter factor B 
 
???? ? ?????    (4) 
 
The X-ray tube output, Y(d), is defined as the quotient of the air kerma at a specified 
distance, d, from the X-ray tube focus by the tube current–exposure time product, PIt, as 
 
???? ? ???????     (5) 
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The air kerma–area product, KAP or PKA, is the integral of the air kerma over the area A of 
the X-ray beam in a plane perpendicular to the beam axis. In this thesis, the more commonly 
used abbreviation, the dose-area product (DAP) is used. The air-kerma length product, PKL, 
is the integral of the air kerma over a line L parallel to the axis of rotation in a CT scanner 
??? ? ? ?????????    (6) 
??? ? ? ?????????    (7) 
The most important quantities for CT dosimetry are the CT air kerma index, Ca,100, the 
weighted CT air kerma index, CW and the volume-weighted CT air kerma index, CVOL, 
which takes into account the helical pitch or axial scan spacing p. In this thesis, the more 
commonly used abbreviation for CVOL, the volume-weighted CT dose index (CTDIvol) is 
used when referring to the original publications. 
?????? ? ?? ? ??????
??
???    (8) 
?? ? ?? ???????????? ? ??????????? ?  (9) 
   ???? ? ???      (10) 
The organ dose DT is a quantity recommended by the ICRP as the appropriate dosimetric 
indicator for the probability of stochastic radiation effects (ICRP 1992). DT is defined as the 
absorbed dose averaged over an organ, i.e., the ratio of the total energy imparted to the tissue 
or organ, ?T̅, to the total mass of the tissue or organ, mT. 
?? ? ?????    (11) 
The effective dose E is defined as the weighted sum of the organ doses. The weighting 
factors are the tissue weighting factor wT and the radiation weighting factor wR. 
 
? ? ? ?? ?? ? ?? ? ?? ? ?????   (12) 
The mean glandular dose MGD or DG is recommended (ICRP 1987; ICRU 2005) for breast 
dosimetry in diagnostic radiology. It is defined as 
 
?? ? ???? ? ? ? ? ? ??   (13) 
 
where g is the conversion factor that considers the radiation quality and breast thickness (50 
% glandularity). Correction factors s and c are for the spectra and glandularity, respectively. 
When no glandularity correction is applied, c = 1. 
 
Conversion coefficients can be used for the assessment of organ and tissue doses. They 
relate the dose to an organ or tissue to a directly measured or calculated dosimetric quantity, 
such as Ka,i, Ka,e, PKA or CVOL. Conversion coefficient is defined as 
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????? ?????? ? ????????????????????????????????? (14) 
 
According to the standard ISO 31-0 (ISO 1992) and its revision, ISO 80000-1 (ISO 2009), 
the term coefficient should be used for a multiplier possessing dimensions, and the term 
factor for a dimensionless multiplier. This convention is not always obeyed consistently in 
the literature. In this thesis the term conversion coefficient is used throughout when 
conversion factors and conversion coefficients are referred to.  
 
Diagnostic reference levels (DRLs) are provided by the national radiation authorities 
according to the requirements of the Basic Safety Standards (BSS), and they are introduced 
in legislation (European Parliament 2014). The BSS require the use of DRLs as a part of the 
optimization of the protection of patients in diagnostic radiology (IAEA 2014). The DRL 
defines the radiation dose level that is not expected to be exceeded for a normal-sized patient 
in an examination performed according to good practices. DRLs are used in the management 
of patient doses in order to ensure that in diagnostic radiology, the dose levels of a selected 
patient cohort, which is selected based on weight or compressed breast thickness (CBT) 
information, are adequate yet not too high for the required diagnostic information. The 
dosimetric quantities recommended for the establishment of DRLs are Ka,i, Ka,e, DG, PKA 
and PKL (ICRU 2005). 
 
The uncertainty of measurement results is typically expressed as expanded uncertainty using 
coverage factors. The combined standard uncertainty uC is defined as 
 
?? ? ????? ?????,   (15) 
 
where uA and uB are the standard uncertainties of type A and B, respectively. Equation (15) 
is valid when the uncertainty sources are not correlated. In the general variance model, this 
results in zero covariance. Generally, for a product or ratio of independent variables, the 
relative weighted variances add, and this is expressed in the propagation of uncertainties as 
a square root of an infinite sum of the squared weights and the squared relative uncertainties. 
(IAEA 2007) 
 
Type A standard uncertainty is the standard deviation (SD) of the mean from a series of 
repeated measurements. Type B standard uncertainty takes into account all sources of 
measurement uncertainty that cannot be estimated by repeated measurements. These can be 
physical uncertainties, such as uncertainty related to positioning of the phantoms and 
dosimeters, X-ray beam intensity, X-ray spectra (in relation to the dosimeters’s response) 
and the angular dependency of dosimeters. The expanded uncertainty U is obtained by 
multiplying uC by a coverage factor k. 
 
? ? ? ? ??    (16) 
 
Typically, k is in the range 2 to 3. When the normal distribution applies, coverage factor k 
= 2 defines an interval having a confidence level of approximately 95% and k = 3 defines 
an interval having a confidence level of greater than 99 %. (IAEA 2007) 
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Figure 1 The relevant dose quantities in patient dosimetry in projection X-ray imaging, 
according to TRS 457 (IAEA 2007). The abbreviations are defined in the text. 
2.2. Imaging modalities 
 
This thesis concentrates on four important diagnostic imaging modalities: general 
radiography, CT, mammography and dental radiography. The level of organ exposure to X-
ray radiation depends on the part of the body being in the primary radiation beam, imaging 
parameters, patient anatomy, radiation quality and the use of radiation shields. The specific 
uncertainties related to each modality examined in this thesis are reviewed briefly according 
to TRS No. 457 (IAEA 2007) and ICRU report No. 74 (ICRU 2005). 
In general, the largest sources of measurement uncertainty in diagnostic dosimetry are the 
quantities related to the direct measurements, namely the intrinsic error, the difference in 
the radiation quality between Secondary Standards Dosimetry Laboratory (SSDL) or 
calibration laboratory and the user, the direction of the radiation incidence, the kerma rate, 
the operating tube voltage, the environmental parameters (air pressure, temperature, 
humidity and electromagnetic compability), the field size and homogeneity and the long 
term stability of the instruments. (IAEA 2007) 
2.2.1. General radiography 
 
General radiography is one of the most basic forms of medical X-ray imaging and it utilizes 
single projections to produce two-dimensional images based on the different attenuation 
properties of tissues and organs. Contrast medium is not used general radiography. The term 
conventional radiography is also used for non-contrast media X-ray examinations, but it 
includes mammography. In single projection imaging, the dose to an organ is high on the 
X-ray beam’s entrance side and low at the exit side. 
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Radiological examination of the thorax is one of the most common diagnostic X-ray 
examination (Helasvuo 2013; Speets et al. 2006; Veldkamp et al. 2009). The thorax can be 
examined in different projections: posterior-anterior (PA), anterior-posterior (AP) and 
lateral (LAT). Thorax PA projection has the advantage of lower absorbed dose to the 
radiosensitive breast tissue compared to the AP projection, where the breasts are at the 
patient entrance where the absorbed dose is highest (Huda & Gkanatsios 1997). Filtration 
of the X-ray beam is used to eliminate the low energy photons that would otherwise increase 
the radiation dose absorbed by the patient. The effect of filtration is seen at the patient 
entrance, and would decrease the dose to the breasts in AP projection. However, the PA 
projection is the standard chest radiograph in standing position together with LAT 
projection; AP projection may be used instead of PA projection in standard examinations if 
the patient is too unwell to stand (Radiology Masterclass 2016). 
In this thesis, general radiography is examined via Monte Carlo simulations without 
dosimetric measurements. The uncertainties in Monte Carlo simulations originate primarily 
from statistical errors. Statistical uncertainties in the doses to organs that are within the X-
ray beam are less than those for organs outside the beam area. In the latter case, the relative 
uncertainty increases with the distance from the scan range. The number of primary photons 
used in the simulation defines the level statistical uncertainties. Other sources of 
uncertainties in Monte Carlo simulations are uncertainties in the attenuation coefficients and 
inadequacies in the model description of the X-ray source and the patient. (ICRU 2005) 
2.2.2. Computed tomography 
 
Computed tomography utilizes combinations of multiple X-ray projections to produce 
cross-sectional tomographic images of specific areas of the patient. The dose quantities used 
in CT, namely Ca,100, CW, CVOL and PKL are defined in standard-sized cylindrical polymethyl 
methacrylate (PMMA) phantoms. The standard cylindrical head and body phantoms have 
diameters of 16 cm and 32 cm, respectively. The internal phantom and patient dose 
distributions are more uniform in CT than in projection imaging. However, the CT dose 
quantities do not correspond to the patient doses, because they cannot consider the different 
patient sizes, genders and patient anatomy. The CT dose quantities are useful in estimating 
the effects of parameter changes to the dose and in comparing protocols between different 
CT devices. 
This thesis concentrates on CT examinations during pregnancy. The most common 
indication for chest CT during pregnancy is suspected pulmonary embolism, whereas for 
abdomino-pelvic CT, the two most common indications are suspected appendicitis and 
trauma (Goldberg-Stein et al. 2011). These indications include both situations where the 
fetus is completely or partly within the scan volume, or outside of it. 
 
The specific sources of measurement uncertainties in computed tomography are the 
precision of reading and tube loading indication, the precision of chamber and phantom 
positioning in the centre of gantry, the uncertainties related to the phantom diameter and the 
depths of measurement bores and the uncertainty in chamber response for measurements 
inside the phantom (IAEA 2007). 
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2.2.3. Mammography 
 
Mammography is a specific type of breast X-ray imaging that uses low energy X-rays to 
detect cancer typically before women experience symptoms. Early detection allows 
treatment at the point when the breast cancer is the most treatable. Standard projections 
(views) in mammography are craniocaudal (CC) projection and mediolateral oblique 
(MLO) projection, which are usually performed on routine screening mammograms for all 
patients. The projection angles in the CC and MLO views are 0º and 45º, respectively. Breast 
compression is used in mammography, because it reduces both breast thickness and 
radiation dose and increases image quality. MGD is the relevant dose quantity in 
mammography, and it is the dose to the glandular tissue of the breast, being dependent on 
the measurable incident air kerma at the patient breast surface, the breast thickness and 
glandularity and the applied radiation quality. Furthermore, CBT is the relevant patient 
thickness in mammography. 
In mammography, a PMMA phantom of 45 mm thickness is generally used and 
recommended to simulate the standard breast of thickness 50 mm and glandularity of 50 % 
(ICRU 2005; European Commission 2006; IAEA 2007; Fitzgerald 1989). PMMA 
equivalent breast thicknesses have been calculated by Dance et al. (Dance 1990; Dance et 
al. 2000) for CBTs of 20 to 110 mm. Furthermore, Dance et al. (Dance 1990; Dance et al. 
2000; Dance et al. 2011) have determined the most recent conversion and correction factors 
for mammography with Monte Carlo simulations, and they are internationally (European 
Commission 2006; IAEA 2007) and nationally (Toroi et al. 2011) recommended for the 
calculation of MGD. This thesis focuses on the differences in the determined MGD for 
patient and phantoms of different thicknesses. 
The specific sources of measurement uncertainties in mammography are the precision of 
reading and tube loading indication, the uncertainty in measurement position, the 
uncertainties related to half value layer (HVL) measurements and the uncertainty in patient 
or phantom thickness (IAEA 2007). 
2.2.4. Dental radiography 
 
Dental radiography includes different sub-modalities that are used for different purposes. 
Intraoral radiography is used to produce an X-ray image of a single tooth or a couple of 
teeth. Panoramic dental examinations provide an image of the whole maxilla and mandible, 
and cephalometric dental examinations are used in orthodontics. CBCT dental examinations 
are a special type of x-ray equipment used when regular dental or facial x-rays are not 
sufficient. CBCT produces three dimensional (3D) images of the teeth and bones in a single 
scan. The highest doses in dental radiography are in the head and neck region; doses in other 
regions are mainly due to scattered radiation. The focus of this thesis is in the radiation 
doses to the fetus and breasts in dental radiography with and without lead shielding. 
The specific sources of measurement uncertainties in dental radiography are the precision 
of reading and the uncertainty in measurement position (IAEA 2007). 
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2.3. Organ dose determination 
 
Accurate estimation of organ doses requires detailed modelling of the patient anatomy and 
the irradiation field (Samei et al. 2014). Patient anatomy depends on the patient size and 
composition, which affect the organ sizes and positions inside the body. The patient size 
can be characterized for example by the mass, height, body mass index or thickness of the 
patient. Also thickness of a certain part of the patient, such as the breast, or size related 
parameters calculated based on the AP and LAT thicknesses can be used to represent the 
patient size. The characterization of the irradiation field in projection imaging considers the 
projection, the field size and the radiation quality, and in CT the tube current modulation 
(TCM) technique, radiation quality, the bowtie filter and the scan range need to be 
considered. The radiation quality can be characterized by the X-ray spectrum. The X-ray 
spectrum is a representation of the radiation intensity as a function of the photon energy and 
the characteristic peaks in the spectrum are defined by the anode material and the maximum 
energy is determined by the tube voltage. Filtration of the spectrum modifies the shape of 
the spectrum, for example by eliminating low energy photons. The parameters and 
properties used to characterize a radiation quality are the anode properties, the HVL, the X-
ray tube voltage and the total filtration (ICRU 2005). 
 
The first difficulty in organ dose determination is that it cannot be measured directly in 
patients, because it would require installation of internal dosimeters in patient’s organs and 
would not be ethically acceptable. There are various methods available for patient organ 
dose estimation and determination. The coarsest and least accurate level of dose estimation 
is to use average or typical tabulated dose value of the examination. The second level are 
organ dose conversion coefficients, that are typically determined based on measurements in 
physical phantoms or Monte Carlo simulations, and the use of conversion coefficients allow 
considering the measurable incident dose. Monte Carlo simulations are the better 
established approach for organ dose conversion coefficient determination, because they are 
well validated and they have the important advantage of flexibility compared to phantom 
measurements (IAEA 2007). The conversion coefficients are the most accurate when they 
are selected based on the information of the patient anatomy and the exposure situation, and 
when the real and the simulated situations match as closely as possible. However, the 
conversion coefficients available do not necessarily cover the case where organ dose 
estimation is needed. Anthropomorphic phantom measurements and Monte Carlo 
simulations that apply straight for the specific case provide a more accurate method for 
organ dose determination, and are especially useful for certain special situations, such as 
pregnant patients.  
 
The most accurate and time consuming method is to use patient specific organ dose 
determination based on dose simulations on the actual CT data of the patient. This approach 
is commonly used in radiation therapy dose calculations, but not in patient dosimetry in 
diagnostic radiology on a routine basis. The organ dose assessment in diagnostic radiology 
is usually made for particular practices and techniques, that are applied to a large number 
or patients, and therefore there is not the same need for individually tailored patient dose 
determination as in radiation therapy (ICRU 2005). This has led to the use of standard 
patient models in diagnostic radiology, but recently patient size-specific dose estimates 
(SSDEs) have been developed for CT by the  American Association of Physicists in 
Medicine (AAPM 2011). For projection radiography, similar patient size-specific dose 
estimates are not yet in general use. 
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2.3.1. Dose detectors and dosimeters 
 
In medical dosimetry, dose detectors and dosimeters are used for example to detect and 
measure the radiation dose inside or outside a subject that is exposed to ionising radiation, 
or the tube output or air kerma of an X-ray device. The selection of an appropriate dose 
measurement device depends on the situation; are the measurements done in the primary 
radiation beam, or does the device see only scattered radiation. 
 
Ionization chambers are gas-filled chambers with two electrodes: anode and cathode. They 
measure the charge from the number of electron-ion pairs created by incident radiation 
within the gas volume (Knoll 2000). There are many different sized and shaped ionization 
chambers for different purposes. In CT, pencil ionization chambers are used in CTDI and 
air kerma measurements. Air kerma measurements in mammography can also be performed 
by low energy ionization chambers. 
 
Solid state detectors are based on semiconductors, and they resemble ionization chambers 
by their operation, but instead of electron-ion pairs, radiation generates electron-hole pairs 
in the semiconducting material, which is usually silicon or germanium. A number of 
electrons are transferred from the valence band to the conduction band, and the same number 
of holes is created in the valence band. However, this is the situation in a completely pure 
semiconductor; in real materials the electrical properties are dominated by very small levels 
of residual impurities (Knoll 2000). Solid state dosimeters can be used for example in tube 
output and scattered radiation dose measurements 
 
Other types of dosimeters used in medical dosimetry are thermoluminescent dosimeters 
(TLDs), radiophotoluminescent dosimeters (RPLDs), optically stimulated dosimeters 
(OSLDs) and metal-oxide-semiconductor field-effect transistors (MOSFETs) (Ristic 2013; 
Manninen 2014; Yoshizumi et al. 2007; Kaasalainen 2015). All these dosimeter types can 
be used to perform organ dose measurements inside anthropomorphic phantoms. MOSFET 
dosimeters allow immediate readout after radiation exposure, which is not feasible with 
TLDs (Yoshizumi et al. 2007). MOSFET dosimeters consist of an insulating layer of silicon 
dioxide (SiO2), a silicon semiconductor substrate and a polycrystalline silicon or metal gate, 
and their operation is based on electron-hole pairs created by ionizing radiation and the 
resulting change in the threshold voltage required to turn on the transistor (Knoll 2000; 
Brady & Kaufman 2012). When MOSFET dosimeters are used with multiple angles of 
irradiation, their angular dependence must be considered. Variation in the angular 
sensitivity of MOSFET dosimeters has been observed, and therefore they should always be 
calibrated in the actual clinical settings for the beam geometry (Koivisto et al. 2013). 
 
Traceability is by definition a continuous calibration chain, in which all stages have 
estimated uncertainties. The traceability of the measured doses to the primary standards is 
provided by the International Measurement System (IMS) for radiation metrology. The IMS 
consists of the Bureau International des Poids et Mesures (BIPM), national Primary 
Standards Dosimetry Laboratories (PSDLs), Secondary Standards Dosimetry Laboratories 
(SSDLs) and radiation users performing measurements (IAEA 2007). International Atomic 
Energy Agency (IAEA) has also a SSDL laboratory and maintains a worldwide network of 
SSDLs. The calibration of radiation instruments used in medical dosimetry is usually 
performed in SSDLs, but calibration services are also provided by the instrument 
manufacturers. In Finland, the Radiation and Nuclear Safety Authority (STUK) is a part of 
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the SSDL. Calibrations of detectors in medical use should be performed at the SSDL on a 
routine basis. Standard radiation qualities are recommended for the calibration of dosimeters 
used in different imaging modalities (IEC 2005; ICRU 2005; IAEA 2007). However, in 
clinical situations the radiation quality can be different from radiation quality used in the 
calibration. 
2.3.2. Anthropomorphic phantoms 
 
One challenge in patient organ dose determination is to mimic the human anatomy 
accurately enough to provide a model for dosimetry. Anthropomorphic phantoms used in 
medical dosimetry can be divided into computational phantoms and physical phantoms. 
Computational phantoms are either mathematical or voxel phantoms. By the end of 2009, 
approximately 121 computational phantoms and 27 physical phantoms have been reported 
in the literature for studies involving ionizing and non-ionizing radiation (Xu & Eckerman 
2009). The majority of the computational phantoms, 84, were constructed from CT or MRI 
images of live subjects or cross sectional photographs of post-mortem subjects (Xu & 
Eckerman 2009). 
 
The first human-like, i.e. anthropomorphic mathematical phantom was developed by Fisher 
and Snyder at Oak Ridge National Laboratory (ORNL) in 1960s (Fisher & Snyder 1966; 
Fisher & Snyder 1967). The work in ORNL continued, and in 1969, the first heterogeneous 
phantom was reported, and it became known as the “MIRD-5 Phantom” (Snyder, Fisher, et 
al. 1969; Snyder, Ford, et al. 1969). The organ masses were selected to follow as closely as 
possible the data of the ICRP Reference Man (ICRP 1975). The MIRD (Medical Internal 
Radiation Dose) phantom has been the basis for numerous derivations representing for 
example family phantom series (Cristy & Eckerman 1987), infants and children of different 
ages (Cristy 1980), gender-specific adult phantoms ADAM and EVA (Kramer et al. 1982) 
and later in 1990s also pregnant female adult phantom (Stabin et al. 1995). The body and 
the organs in the MIRD phantom are simple, geometrical shapes, which is an inborn 
limitation of mathematical phantoms. Many anatomical details in mathematical phantoms 
are compromises that can in some cases lead to inaccurate results (Xu 2014). However, the 
role of mathematical phantoms remain important, and they are used in recent publications 
(Seidenbusch & Schneider 2014; Damilakis, Tzedakis, et al. 2010). 
More realistic voxel phantoms were introduced in the late 1980s, when powerful computer 
and tomographic imaging technologies became available. Voxel phantoms are called the 
second generation phantoms to separate them from the first generation mathematical 
phantoms. Voxel phantoms are based on CT or magnetic resonance imaging (MRI) data 
from which the organs are segmented. In 1990s, two adult male voxel models were 
developed: Voxelman (Zubal 1999) and NORMAN (Dimbylow 1997). The VIP-Man (Xu 
et al. 2000) was the most complex phantom to date, with over 3.7 billion voxels. The GSF 
family of voxel phantoms consists of both pediatric (Veit et al. 1989) and adult phantoms 
of both sexes, different ages and body size (Petoussi-Henss et al. 2002), and it is the most 
comprehensive series of voxel phantoms. Also adult female voxel phantoms representing 
different nationalities have been developed (Dimbylow 2005; Sheng et al. 2013; Sato et al. 
2009). After the construction of the adult and pediatric phantoms, phantoms representing 
different pregnancy stages (Xu et al. 2007; Dimbylow 2006) and phantoms of newborn 
babies (Lee et al. 2007) have been developed. Furthermore, ICRP Reference Male and 
Female voxel phantoms have been constructed in 2009 that resemble the ICRP 89 reference 
values for their body height, weight and organ masses (Zankl & Wittmann 2001; ICRP 
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2002; ICRP 2009). The ICRP Reference Male and Female phantoms are defined to enable 
calculations of the organ and tissue equivalent doses and the effective dose. Voxel phantoms 
that include the whole human body have been used also in mammography (Tzamicha et al. 
2015) and dental radiography (Morant et al. 2013). Dynamic phantoms have also been 
developed that simulate the cardiac and respiratory motion or variable postures (Segars et 
al. 2010; Nagaoka & Watanabe 2009). Many of the most recent phantoms are based on the 
powerful boundary representation methods, which is different from the constructive solid 
geometry method used in earlier voxel phantoms (Xu 2014). 
While mathematical and voxel phantoms are typically used in simulation programs, physical 
anthropomorphic phantoms can also be used in Monte Carlo simulations and dose 
measurements. Physical phantoms contain small cavities for dose measurement devices, 
such as MOSFET dosimeters or TLD dosimeters. For example, CIRS ATOM phantoms of 
different sizes (Computerized Imaging Reference Systems, Norfolk, VA, USA) include 
adult male and female phantoms and pediatric newborn, one-year-old, five-year-old and ten-
year-old phantoms. There is also CIRS ATOM Max dental and diagnostic head phantom to 
be used as a standard of reference for diagnostic radiology of the head. Other commercially 
available physical anthropomorphic phantoms are for example the RANDO phantom (The 
Phantom Laboratory, Salem, NY, USA) and Alderson ART phantoms (Radiology Support 
Devices, Long Beach, CA, USA). In mammography, non-anthropomorphic PMMA breast 
phantom proposed by Dance is recommended for evaluating the glandular dose in a standard 
breast, but several other models have also been developed (Cassola & Hoff 2010). 
2.3.3. Monte Carlo simulations 
 
Monte Carlo simulations are widely used in medical dosimetry. The general requirements 
of a Monte Carlo model are the simulation of the radiation field incident on the patient, the 
photon transport through the patient and the patient anatomy (IAEA 2007; ICRU 2005). In 
medical X-ray imaging, the simulated photon interactions are the photoelectric effect and 
coherent and incoherent scattering because the incident photon energies are below 150 keV 
(ICRU 2005). Voxel-based Monte Carlo simulations require characterization  and 
modelling of the X-ray device and patient anatomy (Gu et al. 2009; Ding et al. 2012; Lee et 
al. 2011; Bostani et al. 2015; Tian et al. 2014; Sinclair et al. 2015; Li et al. 2011a). Modelling 
of the X-ray device requires data for the X-ray spectrum and in CT also for the bowtie filter. 
Furthermore, Monte Carlo simulations may require for example measurement results for air 
kerma quantities (such as Ka or PKA) as the input value. The simulation results can therefore 
be presented as conversion coefficients relative to the input value. All conversion 
coefficients depend on the radiation quality and they are most accurate when the simulated 
situation matches as closely as possible the situation in which the organ doses are required 
(IAEA 2007). 
Three institutes that have published the most comprehensive tabulations of organ dose 
conversion coefficients are the Center for Devices and Radiological Health (CDRH), the 
German Center for Health and the Environment (GSF) and the Health Protection Agency 
(HPA), formerly the National Radiological Protection Board (NRPB) (ICRU 2005). These 
comprehensive tabulations of organ dose conversion coefficients have been determined by 
Monte Carlo simulations, because they are more applicable than measurements in physical 
phantoms when a wide variety of clinical situations or exposure conditions need to be 
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considered (ICRU 2005). However, comparisons between these simulations and measured 
organ doses have been made, and agreement was generally within 30 % for adult phantoms 
and within 40% for paediatric phantoms (ICRU 2005). Additionally, several authors have 
published Monte Carlo simulation based organ dose conversion coefficients for various 
exposure situations (e.g. Zankl et al. 2002; Schlattl et al. 2007; Turner et al. 2011; 
Seidenbusch & Schneider 2014; Johnson et al. 2009; Schultz et al. 1994; Lee et al. 2012; 
Petoussi-Henss et al. 2002). In some cases, doses have been normalized only to the PIt, 
which make it hard to compare the dose conversion coefficient with those normalized to for 
example CVOL. 
The data provided by the GSF and the NRPB have been used in patient dose calculation 
programs. For example, the ImPACT CT Patient Dosimetry Calculator (IMPACT 2011) 
uses the NRPB data and CT-Expo (Stamm & Nagel 2002) uses the GSF data. Patient models 
used in Monte Carlo calculation and simulation programs can be either mathematical or 
voxel phantoms. Some of the calculation programs include assumptions about the beam 
positioning and they use a standard-sized phantom. For example, XDOSE (Le Heron 1994) 
is based on the organ doses generated by the Monte Carlo method described in NRPB-R262 
and NRPB-SR262 (Hart et al. 1994a; Hart et al. 1994b). CALDose_X (Kramer et al. 2008) 
provides an improved patient model by using male and female voxel phantoms instead of a 
standard MIRD-type geometrical patient model used in NRPB-R262 and NRPB-SR262 
(Hart et al. 1994a; Hart et al. 1994b). PCXMC program (Tapiovaara & Siiskonen 2008) 
includes hermaphrodite mathematical phantoms of ages 0, 1, 5, 10, 15 and adult. Principal 
weights and heights of these phantoms are based on the specifications by Cristy & Eckerman 
(1987), which have been modified for PCXMC. ImpactMC program from CT Imaging, 
Erlangen, Germany (Deak et al. 2008; Schmidt & Kalender 2002) allows the user to 
generate 3D dose distributions in CT data of phantoms or patients with user-defined 
acquisition parameters. Several public domain Monte Carlo code systems that can be 
applied to medical dosimetry include for example MCNP (X-5 Monte Carlo Team 2003), 
MCNPX (Pelowitz 2008), EGSnrc (NRC 2016), Geant4 (Agostinelli et al. 2003; Allison et 
al. 2006), PENELOPE (Baró et al. 1995) and Fluka (Battistoni et al. 2007). The large variety 
of mathematical, voxel and physical phantoms available can be used in different Monte 
Carlo simulation programs, which expands the possibilities of organ dose determination in 
medical dosimetry. 
3. Materials and methods 
 
In this thesis, four different imaging modalities were used, and each one is covered by one 
study. Some of the modalities include also sub-modalities. The X-ray devices, imaging 
protocols, phantoms, patient data, performed dose measurements, Monte Carlo simulations 
and calculations related to Studies I-IV are presented. 
3.1. General radiography 
 
In Study I, mathematical phantoms and patient CT data were used in Monte Carlo 
simulations with imaging parameters for thorax PA examination. Monte Carlo programs 
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used were PCXMC 2.0 (Tapiovaara & Siiskonen 2008) and ImpactMC (version 1.4.0.0, 
2014) from CT Imaging, Erlangen, Germany (Deak et al. 2008; Schmidt & Kalender 2002). 
The X-ray spectra used in PCXMC simulations was generated in PCXMC. The X-ray 
spectrum used in ImpactMC simulations was generated using Spektripaja 3.0 (Tapiovaara 
& Tapiovaara 2008), which is based on a semiempirical spectrum model (Birch & Marshall 
1979). In PCXMC simulations, incident air kerma of 1 mGy was used as an input value and 
in ImpactMC simulations, fixed air kerma of 1 mGy was used as an input value and the 
incident air kerma at the FSD was calculated based on the patient thickness.  
 
In Study I, anonymized patient CT data for 5 male and 5 female adult patients investigated 
in 2011 at the Inselspital University Hospital, Bern, Switzerland were used. CT data sets for 
these 10 patients and mathematical PCXMC phantoms thickness-adjusted according to the 
male patients were used in ImpactMC and PCXMC programs, respectively, in order to study 
the effect of patient thickness. In Figures 2 and 3, examples of ImpactMC and PCXMC 
simulations are shown, respectively. The patient selection criteria were that the patients had 
undergone trauma CT, the scanned region covered the lungs and both genders were 
represented equally by 5 five different body sizes, ranging from extra small to small, 
medium, large, and extra large. The patient thickness measured at the mid-sagittal plane at 
the mamilla level in the anterior–posterior (AP) dimension was used to define the patient 
size. The effect of radiation quality was determined in PCXMC for a standard-sized 
PCXMC phantom with four different filtration combinations and a range of tube voltages 
and the corresponding HVLs. 
 
 
Figure 2 ImpactMC simulation of thorax posterior-anterior (PA) examination in Study I. 
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Figure 3 Thorax posterior-anterior (PA) examination on the PCXMC phantom in Study I. 
In Study I, doses from ImpactMC simulations were determined at the mamilla level from 
circular regions of interest (ROIs) in ImageJ (Abramoff et al. 2004) at two different depths 
(back and sternum positions) in the X-ray beam’s trajectory. The position and size of the 
ROIs were adjusted patient-specifically so that the dose distribution inside the ROI area was 
uniform. Computer programs 3DSlicer (version 4.4) and Matlab (version R2014b) were 
used in the segmentation of lungs and breasts from the patient CT data. Breasts were 
segmented for the female patients only and organ doses were determined from the resulting 
volumes of interest (VOIs). In PCXMC, the absorbed doses to lungs and breasts were 
determined as organ doses. Dose conversion coefficients were calculated by dividing the 
ROI doses from ImpactMC simulations and organ doses from ImpactMC and PCXMC 
simulations by the incident air kerma and expressed in μGy/100 μGy. The reference 
conversion factors were calculated for the PCXMC phantom with standard dimensions. The 
relative variation ranges of the conversion coefficients were calculated as the difference 
between the maximum and minimum values relative to the mean value and the reference 
value. 
3.2. Computed tomography 
 
In Study II, CT imaging protocols for trauma, low dose abdomino-pelvic and pulmonary 
angiography were used. 64-MDCT GE LightSpeed VCT scanner (GE Healthcare, 
Milwaukee, WI, USA) was used and the normal clinical examination was simulated as 
closely as possible. Three different pregnancy stages (20, 28, 38 weeks) were constructed 
by positioning gelatin boluses on the anthropomorphic adult female phantom (CIRS ATOM 
702-D, Norfolk, USA), as shown in Figure 4 for the pregnancy stage of 38 weeks. A 
phantom with no bolus represented the pregnancy stage of 12 weeks and non-pregnancy 
stage. 
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Figure 4 CIRS ATOM 702-D phantom and the 38-week gelatin bolus in Study II. 
Prior to the measurements of Study II, ten high sensitivity MOSFET dosimeters were 
calibrated for the energies used in the dose measurements in a clinical CT beam using axial 
scan mode and dose values were registered using a mobileMOSFET 2.4.1. Dose 
Verification System (TN-RD-70-W, Best Medical, Canada). In the calibrations, the 
reference CT air kerma indices (Ca,c) were measured with a RaySafe Xi base unit and a 
RaySafe Xi CT detector (Unfors RaySafe AB, Billdal, Sweden) and calibration factors were 
defined for each of the ten MOSFET dosimeters. In general, the MOSFET calibration 
procedure can be performed by using different methodologies (Brady & Kaufman 2012). 
 
In Study II, the MOSFET dosimeters were placed inside the phantom at nine measurement 
positions (Figure 5, positions B-J), and one dosimeter was placed beneath the centre of the 
bolus on the phantom surface (Figure 5, position A). Measurement positions were selected 
to cover relevant uterus dimensions for all stages of pregnancy considering the possible fetal 
positions. The mean fetal dose was determined for each stage of pregnancy by averaging 
the measured doses corresponding to the estimated uterus volume. Conversion coefficients 
were calculated for each stage of pregnancy and protocol as ratios of mean fetal dose per 
mean CTDIvol.  
 
Additionally to the measurements of Study II, phantom AP and LAT dimensions were 
measured from the DICOM (digital imaging and communications in medicine) images at 
the level of the four surface dosimeters (see Figure 5) to allow comparisons of the measured 
fetal doses to the SSDEs. The effective diameters were calculated as the square root of the 
product of the AP and LAT dimensions, and the SSDEs were calculated based on the 
effective diameters (32 cm PMMA phantom) using the method described in (AAPM 2011). 
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Figure 5 MOSFET dosimeter positions A-J inside CIRS ATOM 702-D phantom in Study II. 
3.3. Mammography 
 
In Study III, semi-circular PMMA phantoms (diameter 16 cm, thicknesses of 5 to 100 mm) 
(Figure 6) were exposed with full AEC (automatic exposure control) mode. Clinical settings 
were used in the exposures by two mammographic devices, diagnostic device Senographe 
Essential (GE Healthcare, Milwaukee, Wisconsin, USA) and screening device Nuance 
(Planmed, Helsinki, Finland), which are referred to as D1 and S1 in this thesis, respectively 
(Table 1). For devices D2–D8 and S2–S3 (Table 1), phantom MGD was determined during 
inspections performed by STUK personnel for a PMMA phantom of 45 mm thickness.  
 
Table 1 The mammographic devices examined in Study III by extensive phantom 
measurements and patient data collections (devices D1 and S1). For other devices 
(D2-D8 and S2-S3), phantom measurements were performed by STUK inspectors 
and patient data was collected by hospital staff. (Study III) 
 
Symbol Manufacturer Model Applied anode/filter 
D1 GE Healthcare Senographe Essential Mo/30 μm Mo 
Mo/25 μm Rh 
Rh/25 μm Rh 
D2 GE Healthcare Performa Mo/30 μm Mo 
D3 Planmed Nuance Excel W/75 μm Ag 
D4 Planmed Nuance Classic Mo/30 μm Mo 
D5 Siemens Mammomat Inspiration W/50 μm Rh 
D6 Siemens Mammomat Inspiration W/50 μm Rh 
D7 Siemens Mammomat Inspiration W/50 μm Rh 
D8 Siemens Mammomat 3000 NOVA Mo/30 μm Mo 
S1 Planmed Nuance W/60 μm Rh  
W/75 μm Ag 
S2 GE Healthcare Alpha Performa Mo/30 μm Mo 
S3 Planmed Nuance Excel W/75 μm Ag 
D = Diagnostic device, S = Screening device 
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Figure 6 Mammography PMMA phantoms from STUK, Helsinki, Finland used in Study III. 
In Study III, dose measurements were performed according to national mammography dose 
protocol (Toroi et al. 2011; Toroi et al. 2013). Ka was measured with an ionisation chamber 
of type 10 × 5-6 M (Radcal Corporation). Y(d) was calculated according to Equation (5). 
HVL was measured by adding additional Al filtration layers on the compression paddle and 
measuring the Al thickness that was needed to halve the Ka. MGDs were calculated 
according to Equation (11). 
 
In Study III, patient data were collected for CC and MLO projections (see Figure 7) so that 
surgically operated breasts and breast implants were excluded from the collection. For 
devices D2–D8 and S2–S3, patient data were collected by hospital staff for a minimum of 
ten patients with breast thicknesses in the range of 40–60 mm, with an average of 50 mm. 
For D1, DoseWatch software (GE Healthcare, Milwaukee, Wisconsin, USA) was used in 
diagnostic patient data collection (patient age interval 22–97 years, time interval 195 days), 
and MGDs for 5342 exposures were determined. For S1, exposure parameters and CBTs 
from 100 screening examinations (patient age interval 50–69 years) were manually 
collected by hospital staff and MGDs for 395 exposures were determined. 
 
 
Figure 7 Patient data was collected in Study III for the standard projections used in 
mammography: right craniocaudal (CC, left image) and right mediolateral oblique 
(MLO, right image).  
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3.4. Dental radiography 
 
In Study IV, the doses were measured as air kerma with a RaySafe Xi unit using 8202062-
C Xi Survey Detector (Unfors RaySafe AB, Billdal, Sweden) inside an anthropomorphic 
adult female phantom (CIRS ATOM 702-D, Norfolk, USA) at the slice 21 position, which 
was removed and replaced with wooden spacers as separators to provide a gap for the dose 
measurement (Figure 8). This position represented the liver level and the apex of the fetal 
coverage in late pregnancy. Doses were also measured at the breast level outside the 
phantom by attaching the detector between the breasts. The average doses at the 
measurement positions were used as the upper estimates for the fetal and breast doses. Fetal 
and breast dose conversion coefficients were calculated as the average dose divided by the 
DAP value of the examination. 
 
 
Figure 8 CIRS ATOM 702-D phantom and wooden spacers in Study IV. 
In Study IV, four dental modalities were used: intraoral, panoramic, cephalometric and 
CBCT. The tube output of the intraoral round cone device (Planmeca ProX, Planmeca, 
Helsinki, Finland) was measured with a RaySafe Xi unit using an 8202031-J Xi R/F & 
MAM detector (Unfors RaySafe AB, Billdal, Sweden). The projections in the Planmeca 
ProX intraoral round cone device were upper occlusal from a +65° vertical angle, which 
served as the worst case scenario for the fetus, mandibular incisor from a -5° vertical angle 
and right maxillary premolar from a +17° vertical angle. A Planmeca Pro Max 2D S2 was 
used in panoramic examinations and a Planmeca ProMax cephalostat was used in lateral 
cephalometric examinations. A Planmeca ProMax 3D Mid (Planmeca) was used in CBCT 
examinations with small, medium, large and extra large fields of view (FOVs). The 
exposure parameters used in all dental modalities examined in Study IV were those 
recommended by the device manufacturer (Planmeca). 
Doses were measured both with and without lead shielding in Study IV. The lead shields 
used were lead shield for thyroid only (Shield 1, 0.5 mmPb, model RA 615, MAVIG), lead 
shield for thyroid, breasts and abdominopelvic region (Shield 2, 0.5 mmPb, model RD 642-
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99, MAVIG) and lead apron for breasts and upper abdomen (Shield 3, 0.5 mmPb, model 
642, MAVIG). Shields 1 and 2 were used in the intraoral modality, and Shield 3 in the other 
modalities according to clinical practice. 
4. Results 
 
Table 2 shows the organs of interest, radiation type (direct or scattered radiation), use of 
shielding and the focuses of each study, which are related to the aims of this thesis.  
Table 2 The studies I-IV included in this thesis. Numbers on parenthesis refer to the aims 1.-
4. of the study. 
Study Modality Organ Direct 
beam/scattered 
radiation 
Shielding Focus (aim number) 
I General 
radiography 
Breasts, lungs Direct + scatter No PCXMC phantom versus 
patients (1) 
Effect of radiation quality 
and patient size (3) 
II CT Fetus Direct + scatter No Conv. coefficients from 
CTDIvol to fetal dose (2) 
Effect of patient size (3) 
III Mammography Glandular 
tissue of the 
breast 
Direct No PMMA phantom versus 
patient (1) 
Effect of radiation quality 
and patient size (3) 
IV Dental 
radiography 
Fetus, breasts Scatter Yes Conv. coefficients from 
DAP to fetal and breast 
dose (2) 
Effect of lead shields (4) 
 
4.1. Comparison of doses to phantoms with doses to patients 
 
In Study I, the ImpactMC results for lungs were up to 16% lower than the PCXMC results 
at the same patient AP thickness. For patients with small AP thickness, the ImpactMC 
results for breasts were up to 52% higher than the PCXMC results, and for patients with 
large AP thickness, the ImpactMC results were up to 55% lower than the PCXMC results. 
AP thickness of 208 mm (female XS) refers to small patients and AP thickness of 269 mm 
(female XL) for large patients, respectively. The results are shown in Figure 9 and Table 6.  
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Figure 9 Comparison of Monte Carlo simulation based organ dose conversion coefficients 
for lungs and breasts for different anterior-posterior (AP) thicknesses at the 
reference radiation quality (120 kV and 4 mmAl + 0.2 mmCu.) (Study I) 
According to Study III, the difference between the phantom (MGDph,c) and patient 
(MGDpa,c) MGD curves calculated with glandularity correction varied from 0 to 25% and 
from 0 to 20% depending on thickness for diagnostic device 1 (D1) and screening device 1 
(S1), respectively. In the thickness range of 40–60 mm, the maximum difference between 
phantom and patient curves was 26% and less than 5% for D1 and S1, respectively. The 
patient and phantom MGD curves of Study III are shown in Figures 10 and 11. 
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Figure 10 Patient and phantom MGDs for diagnostic device 1 (D1) as a function of the 
equivalent breast thickness. Patient mean MGDs calculated with (MGDpa,c, black 
triangles) and without (MGDpa, white triangles) glandularity correction are 
presented with SDs. Mean display values (MGDpa,display, grey triangles) are 
shown for patients. Phantom MGDs calculated with (MGDph,c, black squares) and 
without (MGDph, white squares) glandularity correction. (Study III) 
 
Figure 11 Patient and phantom MGDs for screening device 1 (S1) as a function of the 
equivalent breast thickness. Patient mean MGDs calculated with (MGDpa,c, black 
triangles) and without (MGDpa, white triangles) glandularity correction are 
presented with SDs. Mean display values (MGDpa,display, grey triangles) are 
shown for patients. Phantom MGDs calculated with (MGDph,c, black squares) and 
without (MGDph, white squares) glandularity correction. (Study III) 
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Comparison of MGDs in Study III determined for the standard phantom (MGDph (45 mm)) 
and patients in the CBT range of 40 to 60 mm with an average of 50 mm (mean MGDpa 
(50 mm)) for the devices D1–D8 and S1–S3 (Table 1) is shown in Figure 12. For devices 
D1 and S1, the values calculated without glandularity correction (c = 1) are shown. The 
DLR for MGD in Finland is 1.5 mGy, which is also shown in Figure 12. The difference 
between MGDph (45 mm) and mean MGDpa (50 mm) values was up to 30%, compared to  
MGDph (45 mm). 
 
Figure 12 Standard phantom MGDs (MGDph (45 mm)), and patient mean MGDs (MGDpa 
(50 mm)) for devices D1–D8 and S1–S3. For D1 and S1, the values calculated 
without glandularity correction (c =1) are shown. (Study III) 
4.2. Conversion coefficients for fetal dose estimation 
 
According to Study II, the relative mean fetal doses for trauma protocol in different stages 
of pregnancy (12, 20, 28 and 38 weeks) were in the range of 0.80–0.97 relative to the mean 
CTDIvol. For abdominopelvic protocol, the relative mean fetal dose was 0.57–0.79 and for 
pulmonary angiography protocol, 0.01–0.05 relative to the mean CTDIvol, respectively. 
These relative fetal doses can be used as conversion coefficients in fetal dose estimation in 
different stages of pregnancy and in different CT protocols (see Table 3). The Ca,c reference 
value for these settings was 16 mGy. 
 
In Study IV, fetal dose conversion coefficients were calculated relative to the DAP value, 
both with and without lead shielding for three intraoral projections and panoramic, 
cephalometric and CBCT examinations. Results of Study IV are shown in Tables 4 and 5. 
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Table 3 The measured fetal doses (Df, in mGy) in pregnancy stages of 12, 20, 28 and 38 
weeks with the variation range in parenthesis for trauma, abdomino-pelvic and 
pulmonary angiography CT protocols. Relative fetal doses are calculated relative 
to the mean CTDIvol (in mGy), and serve as fetal dose conversion coefficients (in 
mGy/mGy). (Study II) 
Protocol  12 weeks  20 weeks  28 weeks  38 weeks  
Trauma     
Mean Df 4.60 (4.21-5.26)  4.87 (4.21-5.59)  4.39 (3.30-5.12)  4.64 (3.45-5.46)  
Mean CTDIvol  4.74  5.15  5.30 5.79   
Relative dose  0.97  0.95  0.83  0.80  
Abdomino-pelvic  
Mean Df  
Mean CTDIvol 
 
2.06 (1.83-2.51)  
2.63  
 
2.41 (1.94-3.07)  
3.04 
 
2.14 (1.62-2.61)  
3.22   
 
2.21 (1.79-2.71)  
3.91   
Relative dose  0.78  0.79  0.66  0.57  
Pulmonary 
angiography  
Mean Df  
Mean CTDIvol 
Relative dose 
 
 
0.01 (0.008-0.014)  
1.34 
0.01 
 
 
0.03 (0.006-0.12)  
1.46   
0.02 
 
 
0.06 (0.004-0.25)  
1.54   
0.04 
 
 
0.09 (0.011-0.29)  
1.97   
0.05 
 
Table 4 The measured fetal doses, lead shield dose reduction in percentages and fetal dose 
conversion coefficients calculated relative to the dose-area product (DAP) values in 
intraoral examinations (Study IV). 
 Foetal dose  Breast dose  
 
Modality 
No shield Lead thyroid 
shield 
(Shield 1) 
Lead 
apron and 
thyroid 
shield 
(Shield 2) 
No shield Lead 
thyroid 
shield 
(Shield 1) 
Lead 
apron and 
thyroid 
shield 
(Shield 2) 
Intraoral (μGy)       
Upper occlusal 
Dose reduction (%) 
0.553  0.022  
96 
0.017  
97 
1.882  0.994 
47 
0.016 
99 
Conversion coefficient 
(μGy/Gycm2) 
27.0 1.1 0.8 0.0917 0.0485 0.0008 
Mandibular incisor 
Dose reduction (%) 
0.009  0.006  
39 
- 0.602  0.283  
53 
0.002  
>99 
Conversion coefficient 
(μGy/Gycm2) 
1.0 0.6  67.7 31.8 0.3 
Maxillary premolar (right) 
Dose reduction (%) 
0.012  0.005  
57 
- 0.659  0.512  
22 
0.004  
99 
Conversion coefficient 
(μGy/Gycm2) 
0.7 0.3  39.3 30.5 0.2 
 
  
   
25 
 
Table 5 The measured fetal doses, lead shield dose reduction in percentages and fetal dose 
conversion coefficients calculated relative to the dose-area product (DAP) values in 
panoramic, cephalometric and cone beam computed tomography (CBCT) 
examinations (Study IV). 
 Foetal dose   Breast dose  
 
 
No shield Lead apron 
(shield 3) 
No shield Lead apron 
(shield 3) 
Panoramic dose (μGy) 
Dose reduction (%) 
0.11  0.04  
61 
3.57  0.61  
83 
Conversion coefficient 
(μGy/Gycm2) 
1.5 0.6 50.3 8.6 
Cephalometric dose (μGy) 
Dose reduction (%) 
0.71  0.69  
3 
4.33  0.08  
98 
Conversion coefficient 
(μGy/Gycm2) 
44.4 43.1 270.8 5.2 
CBCT dose (μGy)     
Small FOV 
Dose reduction (%) 
2.64  0.80  
70 
43.20  5.74  
87 
Conversion coefficient 
(μGy/Gycm2) 
4.7 1.4 77.6 10.3 
Medium FOV 
Dose reduction (%) 
3.75  1.10  
71 
61.90  9.09  
85 
Conversion coefficient 
(μGy/Gycm2) 
4.6 1.3 75.5 11.1 
Large FOV 
Dose reduction (%) 
4.52  1.28  
72 
75.26  10.36  
86 
Conversion coefficient 
(μGy/Gycm2) 
4.1 1.2 68.9 9.5 
Extra-large FOV 
Dose reduction (%) 
Conversion coefficient 
(μGy/Gycm2) 
6.93  
 
2.8 
2.11  
69 
0.8 
75.38 
 
30.3  
8.24  
89 
3.3 
FOV = field of view 
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4.3. The effect of patient size on organ doses 
 
In Study I, the highest variations relative to the mean and reference values were found in 
ImpactMC results for breasts (Table 6). For patients with small AP thickness, organ doses 
are up to 5.7 times larger than for patients with large AP thickness. 
 
Table 6 Monte Carlo simulation results for the different patient and phantom anterior-
posterior (AP) thicknesses in thorax posterior-anterior (PA) examination, expressed 
as conversion coefficients calculated relative to the incident air kerma (Study I). 
 
Patient thickness 
  Minimum  
AP thickness: 
194 mm  
Maximum 
AP thickness: 
308 mm  
Mean Reference1  
AP thickness: 
200 mm 
Variation relative to 
mean reference 
  Conversion coefficients (μGy/100μGy) variation range (%) 
PCXMC Lung 102 63 83 96 46 40 
Breast 30 10 19 27 105 73 
ImpactMC Lung 86 56 74 96 40 31 
Breast 402 72 22 27 153 122 
1 PCXMC phantom with standard dimensions 2 The minimum and maximum AP thicknesses for ImpactMC 
breast results are 208 mm and 269 mm, respectively (female extra small and extra large patients) 
In Study II, the automated tube current modulation (ATCM) kept the mean fetal dose rather 
constant through all pregnancy stages in trauma and abdomino-pelvic protocols (Table 3). 
In pulmonary angiography protocol, however, the mean fetal dose increased exponentially 
as the distance from the end of the scan range decreased (Table 3). 
 
In Table 7 the measured AP and LAT dimensions and the calculated effective diameters of 
the female phantom used in Study II are presented for the different pregnancy stages. The 
SSDEs were calculated based on the effective diameters and the CTDIvol values presented 
in Table 3. 
 
Table 7 Measured anterior-posterior (AP) and lateral (LAT) dimensions and the calculated 
effective diameters for Study II. Calculated size-specific dose estimates (SSDEs) 
and measured fetal doses are shown for the different pregnancy stages and 
computed tomography (CT) protocols a, b and c. 
 
Pregnancy 
stage 
(weeks) 
AP 
dimension 
(cm) 
LAT 
dimension 
(cm) 
Effective 
diameter 
(cm) 
Calculated 
SSDE (a/b/c) 
(mGy) 
Mean  
Df(a/b/c)  
(mGy) 
12 20.07 33.26 25.84 6.78/3.76/1.92 4.60/2.06/0.01 
20 24.43 30.66 27.37 7.06/4.16/2.00 4.87/2.41/0.03 
28 25.88 24.33 25.09 7.84/4.77/2.28 4.39/2.14/0.06 
38 27.56 21.23 24.19 8.86/5.98/3.01 4.64/2.21/0.09 
a Trauma, b Abdomino-pelvic, c Pulmonary angiography, SSDE = size-specific dose estimate, Df = fetal dose 
 
The results of Study III showed that the average CBT was close to the nationally used 
reference of 50 mm in diagnostic (average CBT 50 mm, SD 13 mm) and screening (average 
CBT 47 mm, SD 13 mm) examinations. The average MGD for all thicknesses and both CC 
and MLO projections differed by less than 2 % from the MGD determined for breasts in the 
limited CBT range of 40–60 mm (Tables 8 and 9). 
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Table 8 Compressed breast thickness (CBT) and mean glandular dose (MGD) for the 
diagnostic mammographic device D1. The variation ranges are shown in 
parenthesis. (Study III) 
 Projection Displayed mean 
CBT (min-max) 
Displayed mean MGDpa 
(min-max) 
Calculated mean 
MGDpa,c (min-max) 
Calculated mean 
MGDpa (min-max) 
Unit  mm mGy mGy mGy 
All 
thicknesses 
CC, MLO 50.3 (16.0–119.0) 1.26 (0.47–7.20) 1.33 (0.48–6.09) 1.25 (0.41–4.83) 
40-60 mm CC, MLO 49.8 1.26 (0.68–2.19) 1.31 (0.70–2.22) 
 
1.24 (0.62–2.17) 
All 
thicknesses 
CC 47.4 (16.0–86.0) 1.19 (0.57–3.43) 1.24 (0.62–4.02) 1.19 (0.65–3.41) 
40-60 mm CC 49.5 1.22 (0.71–2.19) 1.26 (0.70–2.22) 
 
1.20 (0.68–2.17) 
All 
thicknesses 
MLO 53.0 (19.0–119.0) 1.34 (0.47–7.20) 1.41 (0.48–6.09) 
 
1.31(0.41–4.83) 
40-60 mm MLO 50.2 1.31 (0.68–2.11) 1.35 (0.72–2.11) 1.28 (0.62–2.15) 
CC = craniocaudal, MLO = mediolateral oblique 
 
Table 9 Compressed breast thickness (CBT) and mean glandular dose (MGD) for the 
screening mammographic device S1. The variation ranges are shown in 
parenthesis. (Study III) 
   Projection Displayed mean 
CBT (min-max) 
Displayed mean MGDpa 
(min-max) 
Calculated mean 
MGDpa,c (min-max) 
Calculated mean 
MGDpa (min-max) 
Unit  mm mGy mGy mGy 
All 
thicknesses 
CC, MLO 47.0 (15.0–87.0) 1.27 (0.69–2.29) 
 
1.15 (0.66–1.99) 
 
1.10 (0.71–1.79) 
40-60 mm CC, MLO 48.8 1.25 (0.92–2.02) 1.14 (0.84–1.83) 1.09 (0.84–1.79)  
All 
thicknesses 
CC 45.2 (17.0–78.0) 
 
1.21 (0.74–1.99) 
 
1.10 (0.68–1.79) 1.06 (0.75 – 1.58) 
40-60 mm CC 48.2 1.22 (0.93–1.78) 
 
1.11 (0.86–1.62) 1.06 (0.84 – 1.56) 
All 
thicknesses 
MLO 48.8 (15.0–87.0) 
 
1.33 (0.69–2.29) 
 
1.20 (0.66–1.99) 1.14 (0.71 – 1.79) 
40-60 mm MLO 49.6 1.29 (0.92–2.02) 1.18 (0.84–1.83) 1.12 (0.84 – 1.79) 
CC = craniocaudal, MLO = mediolateral oblique 
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4.4. The effect of radiation quality on organ doses 
 
According to Study I, with the same measurable incident dose level, organ doses differ by 
a factor of up to 3.5 depending on the radiation quality (Table 10). Lung dose conversion 
coefficients are presented as a function of the tube voltage and HVL in Figures 13 and 14, 
respectively. 
 
Table 10 Monte Carlo simulation results for the different radiation qualities in thorax 
posterior-anterior (PA) examination, expressed as conversion coefficients 
calculated relative to the incident air kerma (Study I). 
 
Radiation quality 
  Minimum 
HVL: 
2.6 mmAl  
Maximum 
HVL: 
8.5 mmAl  
Mean 
 
Reference1 
HVL: 
8.1 mm Al 
Variation relative to 
mean reference 
  Conversion coefficients (μGy/100μGy) variation range (%) 
PCXMC Lung 45 98 75 96 71 55 
Breast 8 28 19 27 107 74 
1PCXMC phantom with standard dimensions. 
 
 
 
Figure 13 Lung dose conversion coefficients relative to the incident air kerma from PCXMC 
simulations in thorax posterior-anterior (PA) examination for different total 
filtrations as a function of the tube voltage (Study I). 
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Figure 14 Lung dose conversion coefficients relative to the incident air kerma from PCXMC 
simulations in thorax posterior-anterior (PA) examination for different total 
filtrations as a function of the half value layer (Study I). 
In Study III, the radiation qualities selected by the AEC in phantom and patient exposures 
varied, as can be seen from Tables 11 and 12. For S1, there were no patients with breast 
thickness of 68 mm exposed with the same radiation quality as the phantom with equivalent 
breast thickness of 68 mm. This was also the case for thicknesses of more than 68 mm, 
where the difference in the radiation quality was even larger (Table 12). Non-linearities in 
the phantom data of D1 shown in Figure 10 are due to radiation quality changes (anode, 
filter and tube voltage) as a function of CBT. In Figure 11 this kind of behaviour is not seen 
for S1, because the radiation quality changes are mainly tube voltage changes, and the filter 
is changed only for very small CBTs (Tables 11 and 12). 
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Table 11 PMMA phantom thicknesses and the related equivalent breast thicknesses, mean 
patient compressed breast thicknesses (CBTs) with ranges in parenthesis, 
calculated phantom and mean patient glandular doses (MGDs) with ranges in 
parenthesis and radiation qualities from phantom and patient exposures for the 
diagnostic mammographic device D1 (Study III). 
 
Phantom 
thickness 
(mm) 
Equivalent 
breast 
thickness 
(mm) 
(Dance et al. 
2000) 
Phantom 
MGDph,c 
(mGy) 
Phantom 
MGDph 
(mGy) 
Radiation quality 
from phantom 
exposure 
(anode/filter/kV) 
Mean CBT 
(mm) (range) 
Mean patient 
MGDpa,c (mGy) 
(min-max)  
Radiation qualities 
in patient studies 
(anode/filter/kV) 
20 21 0.73 0.81 Mo/Mo/26 23 (0-25) aa 
n=61 
0.95 (0.50-2.00) Mo/Mo/25,26; 
Mo/Rh/26,27; 
Rh/Rh/29 
30 32 0.88 0.93 Mo/Rh/26 31 (25-35) 
n=753 
1.05 (0.62-2.07) Mo/Mo/25,26; 
Mo/Rh/26,27; 
Rh/Rh/29 
35 40 0.92 0.93 Mo/Rh/27 39 (35-42.5) 
n=1027 
1.19 (0.64-2.74) Mo/Rh/26,27; 
Rh/Rh/29,30,31 
40 45 1.01 0.97 Rh/Rh/29 46 (42.5-47.5) 
n=885 
1.24 (0.70-2.17) Mo/Rh/26,27; 
Rh/Rh/29,30,31 
45 53 1.24 1.13 Rh/Rh/29 51 (47.5-55) 
n=1214 
1.32 (0.74-2.22) Mo/Rh/27; 
Rh/Rh/29,30,31 
50 60 1.27 1.11 Rh/Rh/29 59 (55-65) 
n=1230 
1.44 (0.48-2.29) Mo/Rh/26,27; 
Rh/Rh/29,30,31 
55 68 1.36 1.13 Rh/Rh/30 69 (65-75) 
n=591 
1.60 (0.71-2.90) Mo/Rh/27; 
Rh/Rh/29,30,31 
60 75 1.45 1.18 Rh/Rh/31 78 (75-82.5) 
n=156 
1.80 (1.21-4.16) Rh/Rh/30,31 
65 82 1.71 1.37 Rh/Rh/31 85 (82.5-87.5) 
n=45 
2.03 (1.31-2.96) Rh/Rh/30,31 
70 90 1.46 1.15 Rh/Rh/30    
80 103 2.02 1.57 Rh/Rh/30    
85 109 2.58 2.00 Rh/Rh/30    
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Table 12 PMMA phantom thicknesses and the related equivalent breast thicknesses, mean 
patient compressed breast thicknesses (CBTs) with ranges in parenthesis, 
calculated phantom and mean patient glandular doses (MGDs) with ranges in 
parenthesis and radiation qualities from phantom and patient exposures for the 
screening mammographic device S1 (Study III). 
 
Phantom 
thickness 
(mm) 
Equivalent 
breast 
thickness  
(mm) 
(Dance et al. 
2000) 
Phantom 
MGDph,c 
(mGy) 
Phantom 
MGDph 
(mGy) 
Radiation quality 
from phantom 
exposure 
(anode/filter/kV) 
Mean CBT 
range (mm) 
(range) 
Mean patient 
MGDpa,c (mGy) 
(min-max)  
Radiation qualities 
in patient studies 
(anode/filter/kV) 
20 21 0.73 0.80 W/Rh/29 23 (0-25) aa 
n=36 
0.92 (0.66-1.07) W/Rh/29; 
W/Ag/30 
30 32 0.94 0.98 W/Ag/30 30 (25-35) 
n=45 
1.01 (0.81-1.52) W/Ag/30 
35 40 0.97 0.97 W/Ag/30 40 (35-42.5) 
n=91 
0.99 (0.81-1.65) W/Ag/30 
40 45 1.04 1.02 W/Ag/30 45 (42.5-47.5) 
n=75 
1.11 (0.86-1.83) W/Ag/28,29,30 
45 53 1.21 1.13 W/Ag/30 51 (47.5-55) 
n=77 
1.18 (0.94-1.62) W/Ag/28,29,30,31 
50 60 1.37 1.23 W/Ag/30 59 (55-65) 
n=94 
1.31(0.84-1.79) W/Ag/30,31,32 
55 68 1.56 1.36 W/Ag/31 69 (65-75) 
n=23 
1.51 (1.36-1.98) W/Ag/32,33 
60 75 1.87 1.59 W/Ag/31    
65 82 2.02 1.69 W/Ag/32 79 (75-82.5) 
n=6 
1.72 (1.58-1.99) W/Ag/33 
70 90 2.22 1.83 W/Ag/32 87 (82.5-87.5) 
n=1 
1.72 W/Ag/34 
80 103 2.50 2.04 W/Ag/33    
85 109 2.63 2.14 W/Ag/34    
4.5. The effect of lead shields on organ doses 
 
In Study IV, the effect of the lead shields is presented as the relative dose reduction 
compared with the non-shielded case (Tables 3 and 4). According to Study IV, the use of 
lead shields reduced the fetal dose by 39–97% and the breast dose by 22%–99%, 
respectively. In Study IV, the upper estimates of fetal doses without and with lead shielding 
varied from 0.009 to 6.9 μGy and from 0.005 to 2.1 μGy, respectively. The fetal doses 
without and with lead shielding were far below the level associated with any practical 
radiation detriment to the fetus. The absolute fetal dose levels were considered negligible 
even without lead shielding. 
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5. Discussion 
5.1. Phantoms versus patients in organ dose determination 
 
In X-ray imaging, an anthropomorphic phantom is a model of the human anatomy and its 
X-ray attenuation and absorption properties. The construction and physical properties of 
different phantom types varies, and one should be aware of the conformance of phantom 
and patient doses. In Studies I and III, doses to standard or simplified patient models were 
compared with doses to patients. 
In Study I, lung and breast dose conversion coefficients were determined for mathematical 
phantoms in PCXMC and for patients in ImpactMC based on Monte Carlo simulations. Air 
kerma was used as the input value for the Monte Carlo simulations, but no dose 
measurements were performed. Therefore, the Monte Carlo simulations of Study I are 
independent of dose measurements. In PCXMC, the patient model is based on a MIRD-type 
phantom that does not correspond to a realistic patient. However, the size of the MIRD-type 
phantom can be scaled by changing the phantom height and mass, but the resulting phantom 
thickness does not correspond to the patient thickness, when the actual height and mass of 
the patient are used. Therefore, the phantom mass has to be adjusted so that resulting 
phantom thickness equals the patient thickness. Nevertheless, the thickness-adjusted 
phantoms used in PCXMC do not represent the anatomical changes of different-sized 
patients, since the sizes of all organs and tissues are simply increased or decreased according 
to horizontal and vertical scaling factors. In patients, the amount of adipose tissue is usually 
increased in large patients, but no extra inter-organ adipose tissue is added when the patient 
size increases in PCXMC. The lung doses showed better conformance (differences up to 
16% at the same AP thickness) than the breast doses (differences up to 55% at the same AP 
thickness) between phantoms and patients, as can be seen from Figure 9. The larger relative 
variation ranges in the ImpactMC breast results compared to the PCXMC breast results are 
due to larger variations in the patient anatomy than in the phantom construction. The shapes, 
volumes and locations of the PCXMC phantom breasts are well defined, and do not 
represent the considerable variations that are encountered within patients. Previously it has 
been found that over- or underestimations of several tens of per cent may occur for the 
mathematical models compared to the voxel models, and ranges of variation between 
different voxel models were up to 31% in lung doses and up to 84% in breast doses in the 
PA projection of whole body irradiations (Zankl et al. 2002). 
According to Study III, determining patient MGD using only phantom measurements is 
inaccurate, because phantom measurements do not correspond to an extensive patient 
sample. The difference between 45 mm standard phantom and patient-based (CBTs 40-60 
mm, average 50 mm) MGD estimations was up to 30%. Mammographic PMMA phantoms 
cannot simulate variations in breast composition, but they can provide standardised 
attenuation properties for the AEC, and are therefore appropriate to be used in addition to 
patient dose collections. Compared to other studies about phantom and patient MGDs 
(Avramova-cholakova et al. 2008; Ciraj-Bjelac et al. 2010), differences of up to 20-24% 
between phantom and patient MGDs have been found. However, all these differences are 
less than the recommended limit of 50% of the European protocol on dosimetry in 
mammography (European Commission 1996). 
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5.2. The use of conversion coefficients in fetal dose estimation 
 
In Studies II and IV, fetal dose conversion coefficients were calculated relative to the mean 
CTDIvol (Study II) and DAP (Study IV), respectively. The rationale for providing fetal dose 
conversion coefficients was that they are more applicable than absolute dose values, since 
the fetal dose estimate can be done by multiplying the console CTDIvol or DAP value with 
the suitable conversion coefficient. In Study II, the estimated fetal dose level differs 
depending on the position of the fetus within the primary beam or outside of it, and in Study 
IV depending on the use or absence of lead shielding. The dose absorbed by the uterus has 
typically been used as a surrogate for the dose absorbed by the embryo and fetus in medical 
dosimetry (ACR 2008). As the size of the uterus increases during the pregnancy, different 
methods can be used to consider the larger volume compared to the non-pregnant uterus. 
 
The results of Study II indicate that if the fetus is in the primary beam, an upper estimate of 
the fetal dose can be based on the CTDIvol console value. If the fetus is not in the primary 
beam, the fetal dose estimation requires considering also the distance of the fetus from the 
scan range. The length of the scan range and pregnancy stage should be taken into account 
for further evaluation of the fetal dose. The fetal dose in early pregnancy is very low, when 
the fetus is more than 20 cm from the caudal end of the scan range. When the fetus grows 
during pregnancy and the uterus extends cranially, the distance from the scan range 
decreases, which results in an exponential increase in the fetal dose. Compared to previous 
studies, it has been stated that in direct irradiation of the embryo, the embryo dose will 
depend on the scanned region as well as the scanned length (Huda et al. 2010). If the embryo 
is not directly irradiated, the embryo dose will be determined by the intensity of scattered 
radiation that is mainly dependent on the irradiation geometry (Doshi et al. 2008; Boone et 
al. 2000; Dietrich et al. 2005). However, for tissues that are 20 cm out of the beam, the dose 
is approximately 1% of the dose in the beam (Dietrich et al. 2005). According to Felmlee et 
al. (1990), the fetal dose can be estimated with an error of 15-20% based on pencil ionization 
chamber and TLD measurements in an anthropomorphic phantom. The largest uncertainty 
(25%) is related to the situation where the fetus is partially within the FOV (Damilakis et 
al. 2000). 
The CIRS ATOM phantom (model 702-D) used in Study II represents a relatively small 
female (160 cm, 55 kg) and the uterus dose estimates were up to 43 % lower than the CTDIvol 
value in the abdomino-pelvic examination. According to Monte Carlo based calculations on 
a mathematical phantom representing a 70 kg patient, the uterus dose estimate in the 
abdominal or pelvic CT examinations was 40 % higher than the CTDIvol value (Huda et al. 
2010). These differences in the uterus doses relative to the CTDIvol are likely to be due to 
the construction of the physical CIRS ATOM phantom used in Study II and the 
mathematical phantom used in ImPACT CT Dosimetry Calculator by Huda et al. (2010). 
Furthermore, when constant CT technique factors are used, embryo dose estimates for a 45 
kg patient would be approximately 18 % higher than those for a 70 kg patient, whereas the 
corresponding embryo dose estimates for a 120 kg patient would be approximately 37 % 
lower (Huda et al. 2010). 
  
It has been concluded based on MOSFET measurements in the CIRS ATOM female 
phantom (model 702) that fetal dose in early first trimester correlated with the CTDIvol via 
a linear regression equation in both constant tube current and ATCM modes in trauma, 
abdomino-pelvic and CT angiography protocols (Jaffe et al. 2008; Jaffe et al. 2009). Also a 
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fetal dose conversion coefficient (in mGy/mGy) for chest CT examinations of 0.02 and fetal 
dose conversion coefficients for abdominal CT examinations in the range of 1.01 to 1.15 
have been determined based on TLD measurements in the CIRS ATOM female phantom 
(Helmrot et al. 2007). The fetal dose conversion coefficients during early gestation 
calculated based on the results of Hurwitz et al. (2006) were in line with the results of Study 
II for chest CT for pulmonary embolus, but higher for abdominal CT examinations. In Study 
II, the fetal dose normalised to Ca,c in the abdomino- pelvic protocol in early pregnancy was 
in line with previously published results for GE LightSpeed VCT in early pregnancy 
(Damilakis, Perisinakis, et al. 2010). More recently, it has been concluded that accurate 
estimation of the radiation dose to the conceptus requires a patient-specific approach 
(Lopez-Rendon et al. 2016). 
 
The CTDIvol conversion coefficients for fetal dose estimation determined in Study II were 
compared to other organ dose conversion coefficients. Uterus is normally a relatively 
average-sized organ, located in the middle of the AP dimension of the lower body. For two 
pediatric patients (5 weeks and 12 years old), it has been shown that CTDIvol underestimated 
dose to large organs in the scan coverage by 30% – 48% in chest and abdomino-pelvic CT 
examinations (Li et al. 2011b). In Study II, CTDIvol underestimated dose to the fetus by up 
to 43% in the abdomino-pelvic CT examination. Turner et al. (2011) showed that organ 
doses can be estimated from CTDIvol by multiplying CTDIvol by a size-dependent, scanner-
independent factor. It has also been shown that in adult body CT, dose to an organ fully 
encompassed by the primary radiation beam can be estimated from CTDIvol using a 
protocol-independent conversion coefficient (Li et al. 2012). These kind of general 
conclusions cannot be drawn based on the results of Study II, because Study II was restricted 
to only one scanner and the special case of pregnancy. 
 
In Studies II and IV, the conversion coefficients were based on dose measurements only. 
Recently it has been shown that the difference between organ doses normalized to CTDIvol 
from TLD measurements and Monte Carlo simulations on a 5 year old pediatric CIRS 
ATOM 705-D phantom was within ±20% for most organs, except for the bone marrow, 
breasts and ovaries (Dabin et al. 2016). Measured normalized organ doses were compared 
with those simulated using a tool that provides organ dose estimates for the ICRP reference 
phantoms (Lee et al. 2015). Furthermore, based on measurements on 5 different scanner 
models from the 4 major manufacturers, Dabin et al. (2016) stated that organ doses 
calculated for one CT scanner can be used to assess organ doses from other CT scanners 
with 20% uncertainty (k = 1). 
 
In Study IV, fetal dose conversion coefficients in terms of the DAP value were calculated 
for situations with and without lead shielding. Previously published results on uterus doses 
with and without lead shielding are reviewed in Study IV, but the corresponding DAP values 
are not given in the studies included in the review. Therefore the comparison is done based 
on the absolute doses. In Study IV, the fetal dose measurements were performed the liver 
level, and thus providing the upper estimate of the fetal dose. Three previous studies (Buch 
et al. 2009; Okano et al. 2009; Okano et al. 2012) include dose measurement in the normal 
uterus at one to three measurement points. Consequently, the doses measured at those points 
should be much less than the upper estimates of the fetal dose in Study IV. However, the 
fetal doses measured in Study IV were smaller than the doses measured by Buch et al. (2009) 
in intraoral and panoramic examinations, but larger than those measured in CBCT (Okano 
et al. 2009; Okano et al. 2012). Since the DAP value has been suggested and used as the 
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DRL quantity in dental radiography (Han et al. 2012), it should be the appropriate quantity 
to be used in conversion coefficients. 
5.3. Patient size in organ dose determination 
 
The effect of patient size in organ dose determination was determined for lung and breast 
doses (Study I), fetal doses (Study II) and mean glandular doses of the breast (Study III). In 
Study I, the patient AP thickness was used to determine the patient size. In Study II, the 
focus was on different pregnancy stages and the resulting change in the morphology and 
habitus of the constant-sized phantom, and in Study III, only breasts of different CBTs were 
examined, but the size or thickness of the patient was not studied. 
If patient size is not considered in the choice of the lung dose conversion coefficient, relative 
errors of up to 34% for the PA projection in interventional fluoroscopy procedures can be 
encountered (Johnson et al. 2009). Moreover, it has been found that the organ dose to an 
underweight patient is underestimated and the organ dose to an overweight patient 
overestimated if patient size is not considered when choosing a dose conversion coefficient 
(Johnson et al. 2009). The variation in lung doses between large patients (100 kg in mass 
and 170 cm in height) and an average adult has been reported to be 27% in thorax PA 
examinations, and that the body weight or height alone is a poor parameter for lung dose 
estimation (Tung et al. 2008). The body mass index (BMI) should be used instead, because 
the BMI is approximately linearly proportional to the patient trunk thickness (Tung et al. 
2008).  
As discussed earlier in chapter 5.1., when the size of mathematical phantoms is increased, 
it does not modify the construction of the phantom by addition of inter-organ adipose tissue, 
contrary to large patients, who tend to have larger amount of adipose tissue than smaller 
patients. Furthermore, the breasts of hermaphrodite mathematical phantoms are more fixed 
and they are located symmetrically in the anterior side of the phantom, whereas for patients, 
the size and position of breasts varies substantially. In Study I, the patient thickness had a 
larger relative effect on the breast dose than on the lung dose due to the position of the 
breasts at the patient exit and to the position of the lungs entirely within the primary beam. 
Previously it has been found that breast doses have less correlation with body size than lung 
or liver doses in chest AP examinations due to the position of breasts at the patient surface 
(Zhang et al. 2014). However, it has been stated that in general, organ dose conversion 
coefficients decrease with increasing patient size, due to the increased shielding for most 
organs as the body size increases (IAEA 2007). This effect was also seen in Study I in the 
negative slopes of the linear fits on the ImpactMC results and from the PCXMC results as 
a function of the patient AP thickness (Figure 9).  
On the contrary, in Study III it was seen that as the CBT increases, the MGD values 
increased (Figures 10 and 11). This is due to the AEC that selects an appropriate radiation 
quality based on the pre-exposure: larger breasts require higher tube voltages and different 
anode/filter combinations than smaller breasts. Dance et al. (2000) have studied the average 
breast composition as a function of CBT. The breast has a mixture of adipose and glandular 
tissue. The percentage of glandular tissue decreases differently for age groups of 40-49 years 
and 50-64 years as a function of CBT (Dance et al. 2000). 
 
When the attenuation on the anterior side of the phantom increased due to the added 
pregnancy boluses in Study II, the mean fetal dose remained quite constant because of the 
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ATCM, when the fetus was fully within the scanned volume. Previously, the fetal doses 
from TCM CT examinations have been found to remain quite stable in pregnancy stages of 
15 and 20 weeks, but increase at week 31, both for mathematical and voxel phantom (Gu et 
al. 2013). 
For projection radiography, patient SSDEs are not yet in general use. The SSDEs (AAPM 
2011) provide guidance for patient size corrections in pediatric and adult body CT 
examinations. The SSDE conversion coefficients are given relative to the CTDIvol, and the 
SSDE should correspond to tissue doses, not air kerma or other quantities. However, it has 
been stated that the SSDE allows average dose estimation at the center of a certain CT scan 
range, and that it cannot be used in organ dose estimation (Brink & Morin 2012). Moreover, 
while the SSDE is a simple way to estimate organ doses for relatively large organs located 
fully within the scan volume, for very small organs and organs only partially included in or 
located outside of the scan volume the SSDE will not provide a reasonable estimate of organ 
dose (Christner et al. 2012). It has been found in a study considering pediatric patients, from 
which the largest one was of the same mass as the CIRS ATOM phantom (model 702-D) 
used in Study II, the average correlation between SSDE and organs fully within the scan 
volume was better than ±10 % (Moore et al. 2014). Most recently, organ doses from CT 
have also been determined from post-mortem subjects with direct measurements (Griglock 
et al. 2015; Sinclair et al. 2015). These direct organ dose measurements can estimate organ 
doses more accurately than the calculated SSDE. 
 
Comparison of the calculated SSDEs and measured fetal doses of Study II showed that for 
trauma and abdomino-pelvis protocols, where the fetus is fully within the scan volume, the 
SSDE values differed up to 91% and 171%, respectively, from the measured fetal doses. 
The SSDE values increased as a function of the pregnancy stage, but if the conversion 
coefficients for SSDE calculation are selected based on the AP dimension only, the resulting 
SSDE values are closer to the measured values and remain quite constant. When the fetus 
is outside of the scan volume in pulmonary angiography protocol, the SSDE does not 
provide a reasonable estimate of the fetal dose. 
5.4. Radiation quality in organ dose determination 
 
Study I showed that as a function of the HVL, the lung and breast dose conversion 
coefficients were more convergent than as a function of the tube voltage. This suggests that 
the tube voltage is not a good parameter for specifying the radiation quality alone; the total 
filtration also has to be defined. Previously it has been concluded that at least two specifying 
parameters out of the three (tube voltage, HVL and filtration) should be used (Toroi 2009). 
Compared to other previously published conversion coefficients from DAP to organ doses 
(Drexler et al. 1993; Theocharopoulos et al. 2002; Schultz et al. 1994; Petoussi-Henss et al. 
1995), the results of Study I showed good correspondence. 
 
In Study III, differences between radiation qualities selected by the AEC system for 
phantoms and patients were found. In modern digital mammographic devices, the 
appropriate radiation quality (anode, filter and tube voltage) and X-ray tube current time 
product (mAs) are selected by the AEC system based on breast composition and thickness. 
For small patient sample sizes, there might not be any patients exposed with the same 
radiation quality as the phantom, even if the breast thickness equals the equivalent breast 
thickness, which was the case in Study III with a sample size of 395 exposures. If the same 
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radiation quality is used for PMMA phantoms and breasts, the equivalent breast thicknesses 
given by Dance et al. (2000) seem to work reasonably. It must be noticed that the phantom 
measurement gives only one sample of the possible radiation qualities that can be selected 
by the AEC system. 
 
In diagnostic radiology, the patient radiation doses need to be determined regularly and 
compared to the DRLs. The only modality that has an organ dose, namely MGD, as the 
DRL quantity is mammography, whereas for projection imaging, dental radiography and 
CT, application specific dosimetric quantities, Ka,e, PKA, PKL and CVOL are used as DRLs. 
The uncertainties related to MGD determination are therefore higher than for directly 
measurable dosimetric quantities. The different mammographic devices do not necessarily 
calculate the MGD similarly, and the internal dose calculation method might not be easily 
traceable. Prior to 2011, the Finnish DRL quantity in mammography has been entrance 
surface dose (ESD), but MGD was implemented during the year 2011 for that purpose 
according to the international guidelines (European Commission 2006; IAEA 2007; ICRU 
2005).  
 
The digitalization in diagnostic radiology has increased the range of different radiation 
qualities. The absorption in tissues is dependent on the radiation energy, and the patient dose 
does not remain constant, even if ESD was unchanged (Toroi et al. 2011). MGD is a better 
dose quantity for estimating the radiation risk than ESD, which describes only the dose at 
the patient surface. However, the implementation of organ doses as the DRL quantities in 
other modalities than in mammography would not be applicable due to the fact that organ 
doses cannot be measured directly and the selected method for organ dose determination 
has a marked impact on the related uncertainty. In mammography, which is focused on the 
breast dose only, a simple method for MGD calculation is available and the mammographic 
devices also show the MGD values on the dose display. In other modalities, several organ 
are being irradiated and it would be impossible to provide on a display all the organ doses 
for different patients. However, in the future it would be possible to provide even the SSDE 
on the dose displays, but currently the DRLs are based on the dose quantities that are 
available on the dose displays or that can be directly measured based on patient exposures. 
Moreover, the application specific dose quantities also provide information about the overall 
performance of the devices. 
5.5. Lead shields in radiation protection 
 
The usefulness of lead shielding in dental X-ray examinations was examined in Study IV. 
Despite the relative shielding effect found in Study IV, the exposure-induced increase in the 
risk of breast cancer death for the pregnant patient (based on the breast dose only) (BEIR 
2006; Tapiovaara & Siiskonen 2008) and the exposure-induced increase in the risk of 
childhood cancer death for the unborn child (Doll & Wakeford 1997) are of the same order 
of magnitude, 10-5%. This is a very small value compared to the background risk of 
childhood cancer, which is 0.14% (Doll & Wakeford 1997). Based on the risk estimates, the 
need for fetal and breast lead shielding was considered irrelevant. Most important is that a 
clinically justified dental radiographic examination must never be avoided or postponed due 
to a pregnancy. 
 
However, it is generally recognized that even a 10% reduction in patient dose is a 
worthwhile objective for optimization (IAEA 2007). According to Study IV, the maximum 
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fetal dose levels without lead shielding was less than 1% of the annual dose limit of 1 mSv 
for a member of the public. Compared to the natural background radiation dose rate and the 
dose rate in an airplane at normal cruising altitude, the accumulated dose within two days 
or a 2 hour flight would result in a radiation exposure of the same order of magnitude as the 
upper estimate for fetal dose in dental examinations. Therefore the maximum fetal dose 
levels are minimal, and even though they are further decreased when lead shield are used, 
the use of shielding to reduce the fetal dose could be considered irrelevant. 
 
Compared to other publications on the relevance of lead shielding in dental radiography, it 
has been found in TLD measurements in a full body phantom that there was no statistically 
significant difference between absorbed organ doses in panoramic examinations with or 
without the use of lead apron shielding (Rottke et al. 2013). The opposite has been observed 
by Buch et al. (2009), who found that the use of a lead apron shielding in panoramic 
examinations significantly (72%) reduced the dose to the uterus. However, in full-mouth 
intraoral examinations, the dose reduction effect found by was small (7%) (Buch et al. 
2009). A review article by Okano & Sur (2010) emphasized the importance of thyroid 
shielding especially for pediatric patients, because the thyroid gland is one of the most 
radiosensitive organs in the head and neck region. According to Study IV, thyroid shields 
are used in intraoral and cephalometric dental examinations, but not in panoramic 
examinations, because the shield may interfere with the primary beam. In CBCT, the need 
for thyroid shielding requires local evaluation. In the same review article by Okano & Sur 
(2010), it is further stated that the gonadal doses and doses to the embryo are not significant 
in dental radiography, but the use of lead aprons has been recommended on the grounds of 
patient reassurance (White et al. 2001; Whaites 2002). 
 
The practices related to the use of lead shielding in dental X-ray examinations have varied, 
which is likely to raise unnecessary concerns within the pregnant women, who are unaware 
of their pregnancy at the time of the examination. When they learn about their pregnancy, 
they might be worried, if shielding was not used in their examination. Uniform practices in 
the use of shielding would serve both the dental staff and the patients. The findings of Study 
IV have been noticed in the media, and radiation protection training of dentists and other 
radiation workers is ongoing. The radiation protection legislation is going to change in near 
future, and it is really interesting to see, how attitudes and practices to very small doses are 
going to develop. 
5.6. Uncertainties related to organ dose determination 
 
In chapter 2.2 of this thesis, uncertainties related to each of the studied modalities were 
reviewed according to TRS 457 (IAEA 2007) and ICRU report No. 74 (ICRU 2005). In this 
chapter, those uncertainties are compared to the uncertainties of Studies I-IV and discussed 
briefly. It must be noted that the examples of uncertainty budgets presented in TRS 457 
(IAEA 2007) are for different scenarios; the comparison in this chapter uses the largest 
values. 
The international recommendation for the maximum uncertainty (referred to as the required 
accuracy) of dose measurements in diagnostic radiology is 7% (k = 2) if the value is used 
for the optimization of patient doses (IAEA 2007; ICRU 2005; Wagner et al. 1992). This 
value is related to the uncertainty of dosimetric quantities directly measured by the 
dosimeter and does not include contributions from sources used in conversion of the 
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measured quantity to tissue or organ doses (IAEA 2007). The uncertainty of the initial dose 
value, namely air kerma, is 2% (k = 2) measured in a dosimetry laboratory at one radiation 
quality. However, according to IAEA (2007), an uncertainty of 20% is acceptable in cases 
where the organ dose is low and for radiation survey measurements, but according to ICRU 
(2005), an uncertainty of 30-50% can be accepted when organ doses are low. 
 
The dose detectors used in this thesis have been calibrated either at SSDL of  STUK 
(ionisation chamber of type 10 × 5-6 M (Radcal Corporation)), or by the device manufacturer 
(RaySafe Xi unit with a CT detector, a Survey Detector and a R/F & MAM detector (Unfors 
RaySafe AB, Billdal, Sweden)). The calibration services for detectors in medical use are 
commonly provided only by the manufacturer, even though calibrations at the SSDL should 
be performed on a routine basis. The calibration was performed by Unfors RaySafe in April 
2015. Therefore, the RaySafe Xi unit and its detectors were re-calibrated at STUK in 
September 2016. 
 
Study I did not contain measurements, contrary to Studies II-IV. In Study I, the statistical 
uncertainty in ImpactMC simulations was estimated to be 2.0% (k = 2) at 109 photons. The 
uncertainties based on the minimum and maximum values of the mean doses for the back 
and sternum ROIs in repeated dose determinations were up to 3.2% (k = 2) and 9.0% (k = 
2), respectively, and up to 3.0% (k = 2) for the lung and breast VOIs. The total uncertainty 
of dose values for the back and sternum ROIs was 3.8% (k = 2) and 9.2% (k = 2), 
respectively, and 3.6% (k = 2) for the VOIs in ImpactMC simulations. In PCXMC, the 
statistical uncertainties in organ dose values were up to 1.2% (k = 2) for breasts and up to 
0.4% (k = 2) for lungs at 106 photons. 
 
In Study II, the estimated type B uncertainty in a single MOSFET measurement with the 
applied dose level was 5% (k = 1), and the estimated combined standard uncertainty (type 
A and B) of a single MOSFET measurement was 7% − 11% (k = 1). Bone shadowing was 
considered to have no effect on the angular dependency of the dosimeters, because the 
dosimeters were far from bone structures. The uncertainty of the fetal dose measurement 
was affected mainly by the number of dosimeters within the fetal volume. Dose gradients 
could not be detected with the number of dosimeters used in Study II. The uncertainties of 
fetal dose estimations were larger in pulmonary angiography protocol as the fetus was 
outside the primary beam than in abdomino-pelvic and trauma protocols, where the fetus 
was within the primary beam. The sources of measurement uncertainties in computed 
tomography are related to the direct measurements (6.3%), the precision of reading (1.0%) 
and tube loading indication (1.0%), the precision of chamber and phantom positioning in 
the centre of gantry (0.3%), the uncertainties related to the phantom diameter and the depths 
of measurement bores (0.35%) and the uncertainty in chamber response for measurements 
inside the phantom (3.0%), which yield a combined standard uncertainty of 7.2% (k = 1) 
for CW (IAEA 2007). This value was close to the estimated combined standard uncertainty 
of a single MOSFET measurement in Study II. 
 
In Study III, the uncertainty estimation for MGD included uncertainties associated with air 
kerma calculations (5%), uncertainty in the g-factor tabulated by Dance et al. (2000) (10%), 
uncertainty in the g-factor associated with errors in HVL (2%) and CBT (1%), uncertainty 
in the c-factor tabulated by Dance et al. (2000) (5%) and maximum uncertainty in the s-
factor tabulated by Dance et al. (2000) (4.6%). The estimated combined standard uncertainty 
in patient MGD estimation was therefore 13% (k = 1). The sources of measurement 
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uncertainties in mammography are related to the direct measurements (6.3%), the precision 
of reading (1.0%) and tube loading indication (1.0%), the uncertainty in measurement 
position (0.4%), the uncertainties related to HVL measurements (1.7%) and the uncertainty 
in a 45 mm PMMA phantom (1.7%) or in breast (6.4%) thickness (IAEA 2007). This yields 
a combined standard uncertainty of 6.9% (k = 1) for the phantom and 9.3% (k = 1) for a 
single patient (IAEA 2007). The estimated combined standard uncertainty in patient MGD 
in Study III was slightly larger than the combined standard uncertainty of 9.3%. 
 
In Study IV, the repeatability of the measurements was used as an estimate of the 
measurement uncertainty. The relative variation in repeated measurements was the highest 
at the lowest measured dose level, 0.002 μGy, for which it was 45%. At the highest 
measured dose level, 75.4 μGy, it was 0.5%. The relative variation in repeated 
measurements was in each case lower than the relative dose reduction. The uncertainty of 
the measurement can also be estimated based on the SD of repeated measurements, and the 
minimum and maximum values of the repeated measurements. The combined standard 
uncertainty was therefore 24% (k = 1) at 0.002 μGy and 0.3% (k = 1) at 75.4 μGy. At k = 
2, these values are close to the relative variation in repeated measurements. The sources of 
measurement uncertainties in dental radiography are related to the direct measurements 
(6.3%), the precision of reading (1.0%) and the uncertainty in measurement position (1.2%), 
which yield a combined standard uncertainty of 6.5% (k = 1) (IAEA 2007). The estimated 
combined standard uncertainties in Study IV depend on the measured dose level, being both 
smaller and larger than the combined standard uncertainty of 6.5%. In Study IV, the lowest 
measured dose level was close to the resolution of the used dose detector, which indicates a 
relatively large uncertainty. 
5.7. Future prospects 
 
The studies included in this thesis were mainly based on dose measurements rather than 
Monte Carlo simulations. The studies of this thesis form a whole, that encourages continuing 
research on the topics of this thesis based on Monte Carlo simulations and compare the 
results with the measurements. Ongoing and planned future studies are Monte Carlo studies 
about the effect pelvic lead shielding in thorax PA examination and CBCT examinations, 
iterative reconstruction in ultra-low dose chest CT and fetal doses in CT examinations, for 
example. For these studies, the anthropomorphic female phantom (CIRS ATOM 702-D, 
Norfolk, USA) used in the dose measurements of this thesis will be replaced by a hybrid 
voxel phantom, constructed from the CIRS female phantom and the ICRP Reference Female 
phantom. This approach makes it possible to add the extremities to the CIRS phantom in 
different positions, modify the head tilt angle and use the organ segmentation data of the 
ICRP Reference phantom.  
The results of Study IV of this thesis have been presented by the author in various radiation 
protection trainings after the publication of the article in August 2015. These trainings have 
been targeted not only for dental students and specializing dentists, but also for other groups 
working in hospitals and other areas related to the use of ionizing radiation. The next 
training for dental students and specializing dentists is planned to be in January 2017. 
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6. Conclusions 
 
There are large differences between doses to simplified patient models and patients, up to 
55% in projection imaging and up to 30% in mammography, and the properties and 
limitations of the phantoms have to be understood when phantoms are used as patient 
models.  
Conversion coefficients are more applicable in organ dose estimation than absolute doses, 
because the application specific dosimetric quantities are taken into account. In CT, the 
displayed CTDIvol value can be used as an upper estimate of the fetal dose in examinations, 
where the fetus is completely within the scan volume. When the fetus is outside of the scan 
volume, the fetal dose can be estimated by considering also the distance of the fetus from 
the scan range. In dental radiography, the conversion coefficients were calculated based on 
the measured upper estimates of the fetal dose, and the displayed DAP values can be used 
in fetal dose estimation with the conversion coefficients. 
 
In projection imaging, the lung and breast doses decreased as the patient thickness increased, 
but in mammography, the MGDs increased as the compressed breast thickness increased. 
In CT, the ATCM kept the mean fetal dose quite constant in all studies stages of pregnancy, 
when the fetus was totally within the primary radiation beam. When the fetus was outside 
of the primary beam, the fetal dose increased exponentially, then the distance of the fetus 
from the scan range decreased. In the studied projection imaging examination, the HVL 
alone provides a more convergent specification of the radiation quality than the tube voltage, 
but for the tube voltage it is essential to define also the total filtration. In mammography, 
the effect of the radiation quality is emphasized when phantoms and patient are compared, 
because it is possible that the AEC selects different radiation qualities for patients and 
phantoms, even if the equivalent breast thickness was the same.  
Despite the relative dose reduction achieved with lead shielding, the fetal dose levels 
without lead shielding and the related exposure-induced increase in the risk of childhood 
cancer death were minimal, and therefore the need for abdominal lead shielding was 
considered irrelevant. The exposure-induced increase in the breast cancer death was of the 
same order of magnitude as exposure-induced increase in the risk of childhood cancer death, 
and therefore also breast lead shielding was considered irrelevant. Most important is that a 
clinically justified dental radiographic examination must never be avoided or postponed due 
to a pregnancy. 
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